Menu
Back to Journals » OncoTargets and Therapy » Volume 10 » default
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6431)
- Volume 16, 2023 (140)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 10, 2017
ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman [Retraction]
Gao K, Li H, Huang C, Li H, Fang J, Tian C
OncoTargets and Therapy 2017, 10:5945-5946
Published Date: 18 December 2017
Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging
Guo Y, Wang P, Wang P, Gao W, Li F, Yang X, Ni H, Shen W, Guo Z
OncoTargets and Therapy 2017, 10:5937-5943
Published Date: 15 December 2017
SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma [Retraction]
Huang W, Huang H, Wang L, Hu J, Song W
OncoTargets and Therapy 2017, 10:5935-5936
Published Date: 18 December 2017
Nuclear expression of XBP1s is correlated with breast cancer survival: a retrospective analysis based on tissue microarray
Wang M, Ruan S, Ming J, Dong F
OncoTargets and Therapy 2017, 10:5927-5934
Published Date: 13 December 2017
Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules
He Y, Yang Y, Kuang P, Ren S, Rozeboom L, Rivard CJ, Li X, Zhou C, Hirsch FR
OncoTargets and Therapy 2017, 10:5915-5926
Published Date: 13 December 2017
High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis
Cha GQ, Xu JY, Xu XY, Li B, Lu S, Nanding AB, Hu SL, Liu SL
OncoTargets and Therapy 2017, 10:5907-5914
Published Date: 12 December 2017
miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
Feng X, Liu N, Deng S, Zhang DD, Wang KX, Lu MS
OncoTargets and Therapy 2017, 10:5899-5906
Published Date: 12 December 2017
Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer
Yuan NJ, Zhang G, Bie FJ, Ma M, Ma Y, Jiang X, Wang Y, Hao X
OncoTargets and Therapy 2017, 10:5883-5897
Published Date: 12 December 2017
RETRACTED ARTICLE: Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo
Dong Y, Chang C, Liu J, Qiang J
OncoTargets and Therapy 2017, 10:5873-5882
Published Date: 11 December 2017
Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance
Peng R, Huang X, Zhang C, Yang X, Xu Y, Bai D
OncoTargets and Therapy 2017, 10:5863-5872
Published Date: 11 December 2017
Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells
Cheng X, Liu Z, Shang L, Cai H, Zhang Y, Cai Y, Xu X, Hao J, Wang M
OncoTargets and Therapy 2017, 10:5855-5862
Published Date: 11 December 2017
RETRACTED ARTICLE: Long noncoding RNA NEAT1 promotes nasopharyngeal carcinoma progression through regulation of miR-124/NF-κB pathway
Cheng N, Guo Y
OncoTargets and Therapy 2017, 10:5843-5853
Published Date: 11 December 2017
Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma
Huang JF, Zou QZ, Qian DQ, Zhou LY, Yang B, Chu JJ, Pang QF, Wang KW, Zhang FZ
OncoTargets and Therapy 2017, 10:5835-5841
Published Date: 8 December 2017
The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer
Wu Y, Gong L, Xu J, Mou Y, Xu X, Qian Z
OncoTargets and Therapy 2017, 10:5827-5834
Published Date: 8 December 2017
Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway
Cui LZ, Zhao YW, Pan Y, Zheng X, Shao D, Jia Y, He K, Li K, Chen L
OncoTargets and Therapy 2017, 10:5817-5826
Published Date: 8 December 2017
Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies
Zhu J, Miao C, Liu S, Tian Y, Zhang C, Liang C, Xu A, Cao Q, Wang Z
OncoTargets and Therapy 2017, 10:5805-5816
Published Date: 6 December 2017
The combination astemizole–gefitinib as a potential therapy for human lung cancer
Chávez-López MDG, Zúñiga-García V, Hernández-Gallegos E, Vera E, Chasiquiza-Anchatuña CA, Viteri-Yánez M, Sanchez-Ramos J, Garrido E, Camacho J
OncoTargets and Therapy 2017, 10:5795-5803
Published Date: 6 December 2017
CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway
Chen G, Shi Y, Zhang Y, Sun J
OncoTargets and Therapy 2017, 10:5783-5794
Published Date: 5 December 2017
Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
Zhong W, Zhang L, Ma J, Shao S, Lin R, Li X, Xiong G, Fang D, Zhou L
OncoTargets and Therapy 2017, 10:5775-5782
Published Date: 5 December 2017
Hopea odorata extract inhibits hepatocellular carcinoma via induction of caspase-dependent apoptosis
Nguyen ST, Huynh KL, Nguyen HL, Nguyen Thi Thanh M, Nguyen Trung N, Nguyen Xuan H, Ngoc KP, Truong Dinh K, Pham PV
OncoTargets and Therapy 2017, 10:5765-5774
Published Date: 4 December 2017
Differential radiation response between normal astrocytes and glioma cells revealed by comparative transcriptome analysis
Gong L, Gu JC, Ge JW, Wu X, Zhang C, Yang C, Weng WJ, Gao GY, Feng JF, Mao Q
OncoTargets and Therapy 2017, 10:5755-5764
Published Date: 4 December 2017
Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
Qi X, Jia B, Zhao X, Yu D
OncoTargets and Therapy 2017, 10:5745-5754
Published Date: 1 December 2017
Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
Huang L, Liu Q, Chen S, Shao ZM
OncoTargets and Therapy 2017, 10:5739-5744
Published Date: 1 December 2017
Predictive value of interim PET/CT visual interpretation in the prognosis of patients with aggressive non-Hodgkin’s lymphoma
Liao CC, Qin YY, Tan XH, Hu JJ, Tang Q, Rong Y, Cen H, Li LQ
OncoTargets and Therapy 2017, 10:5727-5738
Published Date: 30 November 2017
Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma
Zheng L, Chen K, Zhu L, Su D, Cheng G
OncoTargets and Therapy 2017, 10:5719-5726
Published Date: 29 November 2017
Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer
Li P, Dong J, Zhou X, Sun W, Huang H, Chen T, Ye B, Zheng Z, Lu M
OncoTargets and Therapy 2017, 10:5711-5718
Published Date: 28 November 2017
Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo
Mori Y, Shirai T, Terauchi R, Tsuchida S, Mizoshiri N, Hayashi D, Arai Y, Kishida T, Mazda O, Kubo T
OncoTargets and Therapy 2017, 10:5703-5710
Published Date: 28 November 2017
Diagnostic significance of circulating long noncoding RNA PCAT6 in patients with non-small cell lung cancer
Wan L, Zhang L, Fan K, Wang JJ
OncoTargets and Therapy 2017, 10:5695-5702
Published Date: 28 November 2017
PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer
Li H, Sun G, Liu C, Wang J, Jing R, Wang J, Zhao X, Xu X, Yang Y
OncoTargets and Therapy 2017, 10:5685-5694
Published Date: 27 November 2017
The combination of systemic therapy and locoregional radiotherapy prolongs survival in newly diagnosed metastatic nasopharyngeal carcinoma patients
Yin Z, Zhang X, Wang Y, Wang P, Yuan Z
OncoTargets and Therapy 2017, 10:5677-5683
Published Date: 27 November 2017
RETRACTED ARTICLE: MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA
Kang M, Shi J, Peng N, He S
OncoTargets and Therapy 2017, 10:5667-5675
Published Date: 28 November 2017
The combination therapy of salinomycin and gefitinib using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells
Zhang Y, Zhang Q, Sun J, Liu H, Li Q
OncoTargets and Therapy 2017, 10:5653-5666
Published Date: 27 November 2017
18F-fluorodeoxyglucose uptake predicts MET expression in lung adenocarcinoma
An S, Zhou X, Liu J, Huang G
OncoTargets and Therapy 2017, 10:5643-5651
Published Date: 27 November 2017
Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism
Markowitz D, Ha G, Ruggieri R, Symons M
OncoTargets and Therapy 2017, 10:5633-5642
Published Date: 24 November 2017
Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer
He L, Zhang S, Zhang X, Liu R, Guan H, Zhang H
OncoTargets and Therapy 2017, 10:5621-5631
Published Date: 24 November 2017
RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer
Xie SY, Li G, Han C, Yu YY, Li N
OncoTargets and Therapy 2017, 10:5605-5619
Published Date: 23 November 2017
Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma
Feng SD, Mao ZM, Liu CY, Nie YS, Sun B, Guo MG, Su CQ
OncoTargets and Therapy 2017, 10:5591-5604
Published Date: 23 November 2017
Clinical application of carbon nanoparticles in curative resection for colorectal carcinoma
Wang LY, Li JH, Zhou X, Zheng QC, Cheng X
OncoTargets and Therapy 2017, 10:5585-5589
Published Date: 22 November 2017
Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer
Deng YX, Lin JZ, Peng JH, Zhao YJ, Sui QQ, Wu XJ, Lu ZH, Gao YH, Zeng ZF, Pan ZZ
OncoTargets and Therapy 2017, 10:5575-5583
Published Date: 22 November 2017
The clinical significance of CXCL5 in non-small cell lung cancer
Wu K, Yu S, Liu Q, Bai X, Zheng X, Wu K
OncoTargets and Therapy 2017, 10:5561-5573
Published Date: 21 November 2017
Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis
Zhao F, Ge YZ, Zhou LH, Xu LW, Xu Z, Ping WW, Wang M, Zhou CC, Wu R, Jia RP
OncoTargets and Therapy 2017, 10:5551-5559
Published Date: 22 November 2017
Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ
Cui J, Chen S, Bo Q, Wang S, Zhang N, Yu M, Wang W, Han J, Zhu Y, Shi B
OncoTargets and Therapy 2017, 10:5541-5550
Published Date: 21 November 2017
Prognostic and clinicopathological significance of ubiquitin-specific protease 22 overexpression in cancers: evidence from a meta-analysis
Ao N, Wang L, Liu Y
OncoTargets and Therapy 2017, 10:5533-5540
Published Date: 21 November 2017
The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population
Qiu H, Wang Y, Kang M, Ding H, Liu C, Tang W, Xiao Z, Chen Y
OncoTargets and Therapy 2017, 10:5525-5532
Published Date: 21 November 2017
The crossroads of breast cancer progression: insights into the modulation of major signaling pathways
Velloso FJ, Bianco AFR, Farias JO, Torres NEC, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC, Zerbini LF, Correa RG
OncoTargets and Therapy 2017, 10:5491-5524
Published Date: 20 November 2017
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma [Corrigendum]
Zhang MC, Yan ZL, Wang JJ, Yao XQ
OncoTargets and Therapy 2017, 10:5489-5490
Published Date: 16 November 2017
Cytomembranic PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma
Zheng L, Cao C, Cheng G, Hu Q, Chen X
OncoTargets and Therapy 2017, 10:5483-5487
Published Date: 16 November 2017
RETRACTED ARTICLE: Curcumin potentiates the potent antitumor activity of ACNU against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways
Zhao J, Zhu J, Lv X, Xing J, Liu S, Chen C, Xu Y
OncoTargets and Therapy 2017, 10:5471-5482
Published Date: 15 November 2017
Identification of COX5B as a novel biomarker in high-grade glioma patients
Hu T, Xi J
OncoTargets and Therapy 2017, 10:5463-5470
Published Date: 15 November 2017
Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature
Zhang L, Zhang C, Yang Z, He M, Zhang L, Ezzat S, Liang X
OncoTargets and Therapy 2017, 10:5459-5462
Published Date: 14 November 2017
Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma
Li Z, Li Y, Yan S, Fu J, Zhou Q, Huang X, Shen L
OncoTargets and Therapy 2017, 10:5445-5458
Published Date: 14 November 2017
Clinical significance of CMTM4 expression in hepatocellular carcinoma
Bei CH, Zhang Y, Wei RM, Zhu XN, Wang ZG, Zeng W, Chen QY, Tan SK
OncoTargets and Therapy 2017, 10:5439-5443
Published Date: 14 November 2017
The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis
Lu J, Li H, Guo P, Shen R, Luo Y, Ge Q, Shi WF, Li Y, Zhu W
OncoTargets and Therapy 2017, 10:5429-5437
Published Date: 13 November 2017
Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms
Ye X, Chen D, Zheng Y, Zhu X, Fu J, Huang J
OncoTargets and Therapy 2017, 10:5425-5428
Published Date: 13 November 2017
Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma
Zhang X, Ji J, Zhang G, Fang C, Jiang F, Ma S, Hou J
OncoTargets and Therapy 2017, 10:5417-5424
Published Date: 13 November 2017
In vitro study on anti-cancer properties of genistein in tongue cancer
Ardito F, Pellegrino MR, Perrone D, Troiano G, Cocco A, Lo Muzio L
OncoTargets and Therapy 2017, 10:5405-5415
Published Date: 13 November 2017
Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis
Chen P, Chen FC, Zhou BH
OncoTargets and Therapy 2017, 10:5391-5403
Published Date: 13 November 2017
LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194
An J, Lv W, Zhang Y
OncoTargets and Therapy 2017, 10:5377-5390
Published Date: 10 November 2017
The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis
Chen X, Cheng J, Huang A, Zhang X, Wang J, Fan J, Zhou J, Yang X
OncoTargets and Therapy 2017, 10:5363-5375
Published Date: 10 November 2017
LncRNA expression and implication in osteosarcoma: a systematic review and meta-analysis
Wang Y, Huang YL, Xiang P, Tian W
OncoTargets and Therapy 2017, 10:5355-5361
Published Date: 9 November 2017
Amatuximab and novel agents targeting mesothelin for solid tumors
Baldo P, Cecco S
OncoTargets and Therapy 2017, 10:5337-5353
Published Date: 8 November 2017
Interleukin-6 upregulates SOX18 expression in osteosarcoma
Wu Z, Yang W, Liu J, Zhang F
OncoTargets and Therapy 2017, 10:5329-5336
Published Date: 8 November 2017
FGF2 promotes metastasis of uveal melanoma cells via store-operated calcium entry
Wang Y, Bao X, Zhang Z, Sun Y, Zhou X
OncoTargets and Therapy 2017, 10:5317-5328
Published Date: 8 November 2017
Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database
Wang S, Gao W, Chen S, Bai L, Luo L, Zheng X, Luo Y
OncoTargets and Therapy 2017, 10:5311-5315
Published Date: 8 November 2017
UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis
Wang B, Shen J, Wang J
OncoTargets and Therapy 2017, 10:5303-5309
Published Date: 6 November 2017
The associations between common SNPs of EFEMP1 gene and glioma risk in Chinese population
Hu J, Dong D, Lu DD
OncoTargets and Therapy 2017, 10:5297-5302
Published Date: 6 November 2017
Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients
Liu XJ, Song YC, Liang P, Su TS, Zhang HJ, Zhao XZ, Yuan ZY, Wang P
OncoTargets and Therapy 2017, 10:5289-5295
Published Date: 6 November 2017
PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells
Guo L, Huang S, Wang X
OncoTargets and Therapy 2017, 10:5281-5288
Published Date: 3 November 2017
S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma
Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N
OncoTargets and Therapy 2017, 10:5273-5279
Published Date: 2 November 2017
Association of GEMIN4 gene polymorphism and the risk of cancer: a meta-analysis
Wu N, Zhang X, Tian J, Yu S, Qiao Y
OncoTargets and Therapy 2017, 10:5263-5271
Published Date: 2 November 2017
Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma
Li YJ, Yao K, Lu MX, Zhang WB, Xiao C, Tu CQ
OncoTargets and Therapy 2017, 10:5255-5261
Published Date: 2 November 2017
Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia
Huang R, Liao XW, Li Q
OncoTargets and Therapy 2017, 10:5243-5254
Published Date: 2 November 2017
Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report
Ma FC, Yu Q, Zeng ZM, He RQ, Mo CH, Zhong JC, Ma J, Feng ZB, Chen G, Hu XH
OncoTargets and Therapy 2017, 10:5237-5242
Published Date: 1 November 2017
MicroRNAs as a novel class of diagnostic biomarkers for the detection of osteosarcoma: a meta-analysis
Liu H, Li P, Chen L, Jian C, Li ZH, Yu AX
OncoTargets and Therapy 2017, 10:5229-5236
Published Date: 1 November 2017
Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis
Gao XL, Zhang M, Tang YL, Liang XH
OncoTargets and Therapy 2017, 10:5219-5228
Published Date: 27 October 2017
RETRACTED ARTICLE: Matrine suppresses the migration and invasion of NSCLC cells by inhibiting PAX2-induced epithelial-mesenchymal transition
Yang J, He D, Peng Y, Zhong HZ, Deng YH, Yu Z, Guan C, Zuo Y, Xu Z
OncoTargets and Therapy 2017, 10:5209-5217
Published Date: 27 October 2017
Current status of poly(ADP-ribose) polymerase inhibitors and future directions
Ohmoto A, Yachida S
OncoTargets and Therapy 2017, 10:5195-5208
Published Date: 26 October 2017
The expression profile and clinical significance of circRNA0003906 in colorectal cancer
Zhuo F, Lin HS, Chen ZX, Huang ZJ, Hu JP
OncoTargets and Therapy 2017, 10:5187-5193
Published Date: 25 October 2017
Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer
Tufman A, Kahnert K, Duell T, Kauffmann-Guerrero D, Milger K, Schneider C, Stump J, Syunyaeva Z, Huber RM, Reu S
OncoTargets and Therapy 2017, 10:5179-5186
Published Date: 25 October 2017
Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer
Fang YH, Hsu CC, Hsieh MJ, Hung MS, Tsai YH, Lin YC
OncoTargets and Therapy 2017, 10:5173-5177
Published Date: 25 October 2017
Low-grade central osteosarcoma in proximal humerus: a rare entity
Tang F, Min L, Zhou Y, Luo Y, Tu CQ
OncoTargets and Therapy 2017, 10:5165-5172
Published Date: 24 October 2017
Overexpression of MPC1 inhibits the proliferation, migration, invasion, and stem cell-like properties of gastric cancer cells
Zhou X, Xiong ZJ, Xiao SM, Zhou J, Ding Z, Tang LC, Chen XD, Xu R, Zhao P
OncoTargets and Therapy 2017, 10:5151-5163
Published Date: 24 October 2017
LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis
Wang P, Chen D, Ma H, Li Y
OncoTargets and Therapy 2017, 10:5137-5149
Published Date: 25 October 2017
Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma
Lin X, Cai L, Qian Z, Wang C, Sun N, Sun X, Huang H, Guo W, Lin H, Yao R
OncoTargets and Therapy 2017, 10:5129-5136
Published Date: 24 October 2017
Long noncoding RNA and mRNA profiling in MDA-MB-231 cells following RNAi-mediated knockdown of SIRT7
Chen KL, Li L, Wang YR, Li CM, Badri TM, Wang GL
OncoTargets and Therapy 2017, 10:5115-5128
Published Date: 24 October 2017
Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer
Ichiki M, Wataya H, Yamada K, Tsuruta N, Takeoka H, Okayama Y, Sasaki J, Hoshino T
OncoTargets and Therapy 2017, 10:5107-5113
Published Date: 24 October 2017
The matrix metalloproteinase and insulin-like growth factor system in oral cancer – a prospective clinical study
Schiegnitz E, Kämmerer PW, Schön H, Gülle C, Berres M, Sagheb K, Al-Nawas B
OncoTargets and Therapy 2017, 10:5099-5105
Published Date: 24 October 2017
Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports
Xie HJ, Xie B, Liu CY, Wang J, Xu Y
OncoTargets and Therapy 2017, 10:5089-5097
Published Date: 24 October 2017
Developing a novel dual PI3K–mTOR inhibitor from the prodrug of a metabolite
Zhou Y, Zhang GY, Wang F, Wang J, Ding YW, Li XY, Shi CT, Li JK, Shih CK, You S
OncoTargets and Therapy 2017, 10:5077-5087
Published Date: 20 October 2017
FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer
Wang D, Wei X, Wang Z, Lu Y, Shi S, Wang N, Qiu M, Wang F, Wang RJ, Li Y, Xu R
OncoTargets and Therapy 2017, 10:5065-5076
Published Date: 19 October 2017
Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma
Gerendash BS, Creel PA
OncoTargets and Therapy 2017, 10:5053-5064
Published Date: 19 October 2017
Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR–ABL transcripts
Dima D, Oprita L, Rosu AM, Trifa A, Selicean C, Moisoiu V, Frinc I, Zdrenghea M, Tomuleasa C
OncoTargets and Therapy 2017, 10:5047-5051
Published Date: 19 October 2017
Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients
Yan X, Liu L, Li H, Qin H, Sun Z
OncoTargets and Therapy 2017, 10:5031-5046
Published Date: 17 October 2017
Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4
Buzzoni R, Carnaghi C, Strosberg J, Fazio N, Singh S, Herbst F, Ridolfi A, Pavel ME, Wolin EM, Valle JW, Oh DY, Yao JC, Pommier R
OncoTargets and Therapy 2017, 10:5013-5030
Published Date: 16 October 2017
Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis
Zhuan-Sun Y, Huang F, Feng M, Zhao X, Chen W, Zhu Z, Zhang S
OncoTargets and Therapy 2017, 10:5005-5012
Published Date: 16 October 2017
Novel strategy of stents in thyroid mass: a case series report of managing severely dyspneic patients
Bhandari A, Wang Y, Lv S, Xia E, Wang O
OncoTargets and Therapy 2017, 10:4997-5004
Published Date: 16 October 2017
Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study
Xu J, Liu X, Yang S, Zhang X, Shi Y
OncoTargets and Therapy 2017, 10:4989-4995
Published Date: 13 October 2017
Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients
Daoud MA, Aboelnaga EM, Alashry MS, Fathy S, Aletreby MA
OncoTargets and Therapy 2017, 10:4981-4988
Published Date: 12 October 2017
Mutation analysis and copy number alterations of KIF23 in non-small-cell lung cancer exhibiting KIF23 over-expression
Vikberg AL, Vooder T, Lokk K, Annilo T, Golovleva I
OncoTargets and Therapy 2017, 10:4969-4979
Published Date: 11 October 2017
Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population
Trachu N, Sirachainan E, Larbcharoensub N, Rattanadech W, Detarkom S, Monnamo N, Kamprerasart K, MunTham D, Sukasem C, Reungwetwattana T
OncoTargets and Therapy 2017, 10:4955-4968
Published Date: 11 October 2017
Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer
Zhang C, Liu C, Wu J, Zheng Y, Xu H, Cheng G, Hua L
OncoTargets and Therapy 2017, 10:4945-4954
Published Date: 11 October 2017
The expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance
Zhang H, Sun Y, Li J, Huang L, Tan S, Yang F, Li H
OncoTargets and Therapy 2017, 10:4935-4943
Published Date: 11 October 2017
Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis
Singh AN, Sharma N
OncoTargets and Therapy 2017, 10:4925-4933
Published Date: 10 October 2017
Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia
Song Y, Peng P, Qiao C, Zhang R, Li J, Lu H
OncoTargets and Therapy 2017, 10:4917-4924
Published Date: 9 October 2017
NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2
Ding N, Wu H, Tao T, Peng E
OncoTargets and Therapy 2017, 10:4905-4915
Published Date: 6 October 2017
let-7d suppresses proliferation and invasion and promotes apoptosis of meningioma by targeting AEG-1
Li H, Zhao J
OncoTargets and Therapy 2017, 10:4895-4904
Published Date: 6 October 2017
Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib
Koutsoukos K, Bamias A, Tzannis K, Espinosa Montaño M, Bozionelou V, Christodoulou C, Stefanou D, Kalofonos H, Duran I, Papazisis K
OncoTargets and Therapy 2017, 10:4885-4893
Published Date: 6 October 2017
Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents
Ayoub NM, Al-Shami KM, Alqudah MA, Mhaidat NM
OncoTargets and Therapy 2017, 10:4869-4883
Published Date: 5 October 2017
ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy
Song F, Zhang J, Li S, Wu J, Jin T, Qin J, Wang Y, Wang M, Xu J
OncoTargets and Therapy 2017, 10:4859-4867
Published Date: 3 October 2017
TERT-CLPTM1 locus polymorphism (rs401681) is associated with the prognosis of hepatocellular carcinoma
Lee HW, Park W, Heo Y, Park TI, Park SY, Lee J
OncoTargets and Therapy 2017, 10:4853-4858
Published Date: 3 October 2017
Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer
Shi T, Jiang R, Wang P, Xu Y, Yin S, Cheng X, Zang R
OncoTargets and Therapy 2017, 10:4841-4851
Published Date: 3 October 2017
Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis
Zhang M, Ma H, Zhang J, He L, Ye X, Li X
OncoTargets and Therapy 2017, 10:4829-4839
Published Date: 3 October 2017
Theranostics in nuclear medicine practice
Yordanova A, Eppard E, Kürpig S, Bundschuh RA, Schönberger S, Gonzalez-Carmona M, Feldmann G, Ahmadzadehfar H, Essler M
OncoTargets and Therapy 2017, 10:4821-4828
Published Date: 3 October 2017
Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1
Li S, Yan T, Deng R, Jiang X, Xiong H, Wang Y, Yu Q, Wang X, Chen C, Zhu Y
OncoTargets and Therapy 2017, 10:4809-4819
Published Date: 3 October 2017
Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?
Rabinowits G
OncoTargets and Therapy 2017, 10:4803-4807
Published Date: 28 September 2017
Clinicopathological features and prognoses in younger and older patients with gastric cancer
Song S, Li C, Li S, Cong X, Xue Y
OncoTargets and Therapy 2017, 10:4795-4802
Published Date: 27 September 2017
Sitting time and occupational and recreational physical activity in relation to the risk of esophageal squamous cell carcinoma
Chen P, Song Q, Han J, Xu H, Chen T, Xu J, Cheng Y
OncoTargets and Therapy 2017, 10:4787-4794
Published Date: 27 September 2017
Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience
Meyer C, Pieper CC, Ahmadzadehfar H, Lampe NA, Matuschek EME, Maschke TA, Enkirch SJ, Essler M, Spengler U, Schild HH
OncoTargets and Therapy 2017, 10:4773-4785
Published Date: 26 September 2017
Molecular classification of esophagogastric junction carcinoma correlated with prognosis
Zou L, Wu Y, Ma K, Fan Y, Dong D, Geng N, Li E
OncoTargets and Therapy 2017, 10:4765-4772
Published Date: 25 September 2017
HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a
Wang Q, Jiang S, Song A, Hou S, Wu Q, Qi L, Gao X
OncoTargets and Therapy 2017, 10:4753-4763
Published Date: 28 September 2017
DNA hypermethylated status and gene expression of PAX1/SOX1 in patients with colorectal carcinoma
Huang J, Tan ZR, Yu J, Li H, Lv Q, Shao Y, Zhou H
OncoTargets and Therapy 2017, 10:4739-4751
Published Date: 26 September 2017
Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors
Xu PP, Guo D, Shao XY, Peng MX, Chen B
OncoTargets and Therapy 2017, 10:4731-4738
Published Date: 25 September 2017
Quercetin inhibits epithelial–mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial–mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells
Yu D, Ye T, Xiang Y, Shi Z, Zhang J, Lou B, Zhang F, Chen B, Zhou M
OncoTargets and Therapy 2017, 10:4719-4729
Published Date: 25 September 2017
Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors
Ma Z, Huang H, Xu Y, He X, Wang J, Hui B, Ji H, Zhou J, Wang K
OncoTargets and Therapy 2017, 10:4711-4717
Published Date: 25 September 2017
RNAi-mediated knockdown of CAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2
Jiang L, Xu G, Li Z, Zeng X, Li Z, Liu J, Mei L, Li X
OncoTargets and Therapy 2017, 10:4701-4709
Published Date: 25 September 2017
High expression of Sam68 in sacral chordomas is associated with worse clinical outcomes
Wen H, Li P, Ma H, Zheng J, Yu Y, Lv G
OncoTargets and Therapy 2017, 10:4691-4700
Published Date: 22 September 2017
Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review
Zhang Y, Qi Y, Wang A, Ma B, Fu X, Zhao L, Gao Q
OncoTargets and Therapy 2017, 10:4687-4690
Published Date: 22 September 2017
Targeting the androgen receptor in triple-negative breast cancer: current perspectives
Mina A, Yoder R, Sharma P
OncoTargets and Therapy 2017, 10:4675-4685
Published Date: 20 September 2017
Clinical significance of SLP-2 in hepatocellular carcinoma tissues and its regulation in cancer cell proliferation, migration, and EMT
Huang Y, Chen Y, Lin X, Lin Q, Han M, Guo G
OncoTargets and Therapy 2017, 10:4665-4673
Published Date: 20 September 2017
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy
Carloni S, Gallerani G, Tesei A, Scarpi E, Verdecchia GM, Virzì S, Fabbri F, Arienti C
OncoTargets and Therapy 2017, 10:4657-4664
Published Date: 20 September 2017
The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis
Pang Q, Jin H, Qu K, Man Z, Wang Y, Yang S, Zhou L, Liu H
OncoTargets and Therapy 2017, 10:4645-4656
Published Date: 20 September 2017
HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma
Maroto P, Esteban E, Fernández Parra E, Mendez-Vidal MJ, Domenech M, Pérez-Valderrama B, Calderero V, Pérez-Gracia JL, Grande E, Algaba F
OncoTargets and Therapy 2017, 10:4635-4643
Published Date: 20 September 2017
NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy
Chang B, Park MJ, Choi SI, In KH, Kim CH, Lee SH
OncoTargets and Therapy 2017, 10:4625-4633
Published Date: 19 September 2017
The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer
Mahecha AM, Wang H
OncoTargets and Therapy 2017, 10:4617-4624
Published Date: 19 September 2017
Effect of temozolomide on survival in elderly patients with glioblastoma and impaired performance status: a propensity score-matching analysis [Corrigendum]
Liu Y, Liu P, Shao W, Du H, Li Z, Guo C, Li Z
OncoTargets and Therapy 2017, 10:4615-4616
Published Date: 18 September 2017
EGFR with TKI-sensitive mutations in exon 19 is highly expressed and frequently detected in Chinese patients with lung squamous carcinoma
Memon AA, Zhang HP, Gu Y, Luo Q, Shi JJ, Deng Z, Ma J, Ma W
OncoTargets and Therapy 2017, 10:4607-4613
Published Date: 18 September 2017
Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy
Sunakawa Y, Izawa N, Mizukami T, Horie Y, Hirakawa M, Arai H, Ogura T, Tsuda T, Nakajima TE
OncoTargets and Therapy 2017, 10:4599-4605
Published Date: 15 September 2017
Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis
Meng Q, Shi S, Liang C, Liang D, Xu W, Ji S, Zhang B, Ni Q, Xu J, Yu X
OncoTargets and Therapy 2017, 10:4591-4598
Published Date: 15 September 2017
DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival
Banas T, Pitynski K, Okon K, Czerw A
OncoTargets and Therapy 2017, 10:4579-4589
Published Date: 14 September 2017
Polygonatum odoratum lectin promotes BECN1 expression and induces autophagy in malignant melanoma by regulation of miR1290
Luan W, Qian Y, Ni X, Chanda TK, Xia Y, Wang J, Yan Y, Xu B
OncoTargets and Therapy 2017, 10:4569-4577
Published Date: 14 September 2017
CYP19A1 gene polymorphism and colorectal cancer etiology in Saudi population: case–control study
Al-Mukaynizi FB, Alanazi M, Al-Daihan S, Parine NR, Almadi M, Aljebreen A, Azzam N, Alharbi O, Arafah M, Warsy A
OncoTargets and Therapy 2017, 10:4559-4567
Published Date: 14 September 2017
Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy
Luo C, Shen JY, Ying J, Fang XH, Wang XH, Fu ZX, Liu P
OncoTargets and Therapy 2017, 10:4553-4557
Published Date: 14 September 2017
Clinicopathological significance of HSP27 in gastric cancer: a meta-analysis
Ge H, He X, Guo L, Yang X
OncoTargets and Therapy 2017, 10:4543-4551
Published Date: 13 September 2017
Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: clinical impact of alectinib
Muller IB, de Langen AJ, Giovannetti E, Peters GJ
OncoTargets and Therapy 2017, 10:4535-4541
Published Date: 13 September 2017
Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
Tang Y, Qiao G, Xu E, Xuan Y, Liao M, Yin G
OncoTargets and Therapy 2017, 10:4527-4534
Published Date: 12 September 2017
Adenocarcinoma of the lung with EGFR gene mutation and subsequent resistance mechanisms exploration: case report
Xu L, Wang QZ, Wu L
OncoTargets and Therapy 2017, 10:4517-4525
Published Date: 12 September 2017
The non-small cell lung cancer EGFR extracellular domain mutation, M277E, is oncogenic and drug-sensitive
Yu S, Zhang Y, Pan YJ, Cheng C, Sun YH, Chen HQ
OncoTargets and Therapy 2017, 10:4507-4515
Published Date: 12 September 2017
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Liao X, Huang K, Huang R, Liu X, Han C, Yu L, Yu T, Yang C, Wang X, Peng T
OncoTargets and Therapy 2017, 10:4493-4506
Published Date: 12 September 2017
Predictive factors and prognosis for recurrent laryngeal nerve invasion in papillary thyroid carcinoma
Chen W, Lei J, You J, Lei Y, Li Z, Gong R, Tang H, Zhu J
OncoTargets and Therapy 2017, 10:4485-4491
Published Date: 11 September 2017
Cervical level IIb metastases in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis
Kou Y, Zhao T, Huang S, Liu J, Duan W, Wang Y, Wang Z, Li D, Ning C, Sun C
OncoTargets and Therapy 2017, 10:4475-4483
Published Date: 11 September 2017
Oncogenic role of microRNA-20a in human multiple myeloma
Wang T, Tao W, Zhang L, Li SL
OncoTargets and Therapy 2017, 10:4465-4474
Published Date: 11 September 2017
miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells
Li X, Li Y, Wan L, Chen R, Chen F
OncoTargets and Therapy 2017, 10:4455-4464
Published Date: 11 September 2017
Targeted interfering DEP domain containing 1 protein induces apoptosis in A549 lung adenocarcinoma cells through the NF-κB signaling pathway
Wang Q, Li A, Jin J, Huang G
OncoTargets and Therapy 2017, 10:4443-4454
Published Date: 11 September 2017
Intraoperative measurement of thyroglobulin in lymph node aspirates for the detection of metastatic papillary thyroid carcinoma
Wang Y, Liu Y, Wang X, Li X, Jiang R, He X
OncoTargets and Therapy 2017, 10:4435-4441
Published Date: 11 September 2017
Prognostic immune-related gene models for breast cancer: a pooled analysis
Zhao J, Wang Y, Lao Z, Liang S, Hou J, Yu Y, Yao H, You N, Chen K
OncoTargets and Therapy 2017, 10:4423-4433
Published Date: 11 September 2017
Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer
Yang F, Gao JY, Chen H, Du ZH, Zhang XQ, Gao W
OncoTargets and Therapy 2017, 10:4413-4422
Published Date: 11 September 2017
Marketed drugs used for the management of hypercholesterolemia as anticancer armament
Papanagnou P, Stivarou T, Papageorgiou I, Papadopoulos GE, Pappas A
OncoTargets and Therapy 2017, 10:4393-4411
Published Date: 8 September 2017
Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway
Hu B, Lv X, Gao F, Chen S, Wang S, Qing X, Liu J, Wang B, Shao Z
OncoTargets and Therapy 2017, 10:4379-4391
Published Date: 8 September 2017
Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population
Lin Y, Fu F, Chen Y, Qiu W, Lin S, Yang P, Huang M, Wang C
OncoTargets and Therapy 2017, 10:4369-4378
Published Date: 7 September 2017
Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt’s lymphoma and acute lymphoblastic leukemia
Weagel EG, Meng W, Townsend MH, Velazquez EJ, Brog RA, Boyer MW, Weber KS, Robison RA, O'Neill KL
OncoTargets and Therapy 2017, 10:4355-4367
Published Date: 6 September 2017
Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report
Jovanovic D, Stevic R, Velinovic M, Kontic M, Maric D, Spasic J, Radosavljevic D
OncoTargets and Therapy 2017, 10:4347-4354
Published Date: 6 September 2017
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma
Zhang MC, Yan ZL, Wang JJ, Yao XQ
OncoTargets and Therapy 2017, 10:4339-4346
Published Date: 1 September 2017
Inhibitory effects of a selective Jak2 inhibitor on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT20 cells
Asari Y, Kageyama K, Nakada Y, Tasso M, Takayasu S, Niioka K, Ishigame N, Daimon M
OncoTargets and Therapy 2017, 10:4329-4338
Published Date: 1 September 2017
Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer: a systematic review and meta-analysis
Liu G, Xiong DS, Zeng JJ, Chen BR, Huang ZJ
OncoTargets and Therapy 2017, 10:4321-4328
Published Date: 1 September 2017
The role and significance of VEGFR2+ regulatory T cells in tumor immunity
Zhu PR, Hu CX, Hui KY, Jiang XD
OncoTargets and Therapy 2017, 10:4315-4319
Published Date: 1 September 2017
Nuclear factor-kappa B1 inhibits early apoptosis of glioma cells by promoting the expression of Bcl-2
Yang TQ, Chen M, Wang YQ, Xu W, Han Y, Xu J, Xiang YJ, Yuan B, Wang HZ, Zhou YX
OncoTargets and Therapy 2017, 10:4305-4313
Published Date: 31 August 2017
Improvement of survival for non-small cell lung cancer over time
Xia W, Yu X, Mao Q, Xia W, Wang A, Dong G, Chen B, Ma W, Xu L, Jiang F
OncoTargets and Therapy 2017, 10:4295-4303
Published Date: 29 August 2017
Synaptotagmin-7 is overexpressed in hepatocellular carcinoma and regulates hepatocellular carcinoma cell proliferation via Chk1–p53 signaling
Jin H, Xu G, Zhang Q, Pang Q, Fang M
OncoTargets and Therapy 2017, 10:4283-4293
Published Date: 29 August 2017
Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer
Liang S, Xu K, Niu L, Wang X, Liang Y, Zhang M, Chen J, Lin M
OncoTargets and Therapy 2017, 10:4273-4281
Published Date: 28 August 2017
Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation
Zeng D, Wang C, Huang J, Jiang J
OncoTargets and Therapy 2017, 10:4269-4272
Published Date: 28 August 2017
Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients
Peng L, Wang YN, Tang YM, Zeng L, Liu JF, Zeng Z, Liu J, Shi P, Ye XH, Zhao Q
OncoTargets and Therapy 2017, 10:4261-4267
Published Date: 28 August 2017
LEF1-AS1, a long non-coding RNA, promotes malignancy in glioblastoma
Wang J, Liu X, Yan C, Liu J, Wang S, Hong Y, Gu A, Zhao P
OncoTargets and Therapy 2017, 10:4251-4260
Published Date: 28 August 2017
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors
Creelan BC, Gabrilovich DI, Gray JE, Williams CC, Tanvetyanon T, Haura EB, Weber JS, Gibney GT, Markowitz J, Proksch JW, Reisman SA, McKee MD, Chin MP, Meyer CJ, Antonia SJ
OncoTargets and Therapy 2017, 10:4239-4250
Published Date: 29 August 2017
miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples
Braicu OL, Budisan L, Buiga R, Jurj A, Achimas-Cadariu P, Pop LA, Braicu C, Irimie A, Berindan-Neagoe I
OncoTargets and Therapy 2017, 10:4225-4238
Published Date: 28 August 2017
Initial experience of correlating diffusion spectral parameters with histopathologic indexes in murine colorectal tumor homografts
Zhang XY, Li XT, Sun J, Sun YS
OncoTargets and Therapy 2017, 10:4213-4223
Published Date: 26 August 2017
HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer
Cao S, Sun J, Lin S, Zhao L, Wu D, Liang T, Sheng W
OncoTargets and Therapy 2017, 10:4205-4211
Published Date: 26 August 2017
Investigation of proliferation and migration of tongue squamous cell carcinoma promoted by three chemokines, MIP-3α, MIP-1β, and IP-10
Chu H, Jia B, Qiu X, Pan J, Sun X, Wang Z, Zhao J
OncoTargets and Therapy 2017, 10:4193-4203
Published Date: 29 August 2017
Clinical applications of dendritic cells–cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: an up-to-date meta-analysis
Zhang YC, Zhang X, Zhang AQ, Li K, Qu K
OncoTargets and Therapy 2017, 10:4173-4192
Published Date: 23 August 2017
miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer
Ma M, Chen S, Liu Z, Xie H, Deng H, Shang S, Wang X, Xia M, Zuo C
OncoTargets and Therapy 2017, 10:4161-4171
Published Date: 22 August 2017
AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells
Lee D, Yu EJ, Ham I, Hur H, Kim Y
OncoTargets and Therapy 2017, 10:4153-4159
Published Date: 22 August 2017
RASSF1A hypermethylation is associated with ASXL1 mutation and indicates an adverse outcome in non-M3 acute myeloid leukemia
Liu F, Gong M, Gao L, Cai X, Zhang H, Ma Y
OncoTargets and Therapy 2017, 10:4143-4151
Published Date: 22 August 2017
Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma
Saji H, Sakai H, Kimura H, Miyazawa T, Marushima H, Nakamura H
OncoTargets and Therapy 2017, 10:4135-4141
Published Date: 21 August 2017
Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant
Zhao Z, Song ZJ, Wang XW, Sun HF, Yang XM, Yuan Y, Yu P
OncoTargets and Therapy 2017, 10:4129-4133
Published Date: 21 August 2017
Osteopontin and vasculogenic mimicry formation are associated with response to neoadjuvant chemotherapy in advanced breast cancer
Gu M, Zheng X
OncoTargets and Therapy 2017, 10:4121-4127
Published Date: 18 August 2017
Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer
Chen Y, Tang W, Pan X, Wu C, Cao Y, Yang W
OncoTargets and Therapy 2017, 10:4113-4119
Published Date: 17 August 2017
Clinicopathologic characteristics, therapy and outcomes of patients with primary ureteral small cell carcinoma: a case series and systematic review of the literature
Zhong W, Lin R, Zhang L, Jin C, Li X, He Q, Gong K, He Z, Zhou L
OncoTargets and Therapy 2017, 10:4105-4111
Published Date: 17 August 2017
Chest reconstruction using a custom-designed polyethylene 3D implant after resection of the sternal manubrium
Lipińska J, Kutwin L, Wawrzycki M, Olbrzymek L, Jabłoński S
OncoTargets and Therapy 2017, 10:4099-4103
Published Date: 17 August 2017
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations
Patel SA, Hoffman-Censits J
OncoTargets and Therapy 2017, 10:4089-4098
Published Date: 17 August 2017
CT-guided 125I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy
Tong L, Liu P, Huo B, Guo Z, Ni H
OncoTargets and Therapy 2017, 10:4081-4088
Published Date: 17 August 2017
Carcinogenicity of chromium and chemoprevention: a brief update
Wang Y, Su H, Gu Y, Song X, Zhao J
OncoTargets and Therapy 2017, 10:4065-4079
Published Date: 16 August 2017
The role of desmosomes in carcinogenesis
Zhou G, Yang L, Gray A, Srivastava AK, Li C, Zhang G, Cui T
OncoTargets and Therapy 2017, 10:4059-4063
Published Date: 14 August 2017
Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer
Lv RB, Wang QG, Liu C, Liu F, Zhao Q, Han JG, Ren DL, Liu B, Li CL
OncoTargets and Therapy 2017, 10:4051-4057
Published Date: 14 August 2017
An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in papillary renal cell carcinoma
Huang CG, Yuan NJ, Wu LY, Wang XF, Dai JQ, Song P, Li FX, Xu CB, Zhao XH
OncoTargets and Therapy 2017, 10:4037-4050
Published Date: 14 August 2017
Effect of temozolomide on survival in elderly patients with glioblastoma and impaired performance status: a propensity score–matching analysis
Liu Y, Liu P, Shao W, Du H, Li Z, Guo C, Li Z
OncoTargets and Therapy 2017, 10:4029-4035
Published Date: 14 August 2017
Low concentration of quercetin antagonizes the invasion and angiogenesis of human glioblastoma U251 cells
Liu Y, Tang Z, Yang J, Zhou Y, Meng L, Wang H, Li C
OncoTargets and Therapy 2017, 10:4023-4028
Published Date: 11 August 2017
Perihippocampal metastasis following hippocampus-avoiding prophylactic cranial irradiation for small cell lung cancer: a case report
Yeo SG
OncoTargets and Therapy 2017, 10:4017-4021
Published Date: 11 August 2017
Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy
Chen L, Hao Y, Zhu LH, Li S, Zuo YJ, Zhang YX, Song HJ, Xue YW
OncoTargets and Therapy 2017, 10:4007-4016
Published Date: 10 August 2017
Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases
Xie ZC, Dang YW, Wei DM, Chen P, Tang RX, Huang Q, Liu JH, Luo DZ
OncoTargets and Therapy 2017, 10:3991-4005
Published Date: 10 August 2017
Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigen
Shibaguchi H, Luo N, Shirasu N, Kuroki M, Kuroki M
OncoTargets and Therapy 2017, 10:3979-3990
Published Date: 22 August 2017
Fucosyltransferase VII promotes proliferation via the EGFR/AKT/mTOR pathway in A549 cells
Liang J, Gao W, Cai L
OncoTargets and Therapy 2017, 10:3971-3978
Published Date: 7 August 2017
Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma
Li J, Wang L
OncoTargets and Therapy 2017, 10:3965-3969
Published Date: 7 August 2017
Therapies for acute myeloid leukemia: vosaroxin
Sayar H, Bashardoust P
OncoTargets and Therapy 2017, 10:3957-3963
Published Date: 7 August 2017
Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target
Sun M, Zhao W, Zeng Y, Zhang D, Chen Z, Liu C, Wu B
OncoTargets and Therapy 2017, 10:3949-3956
Published Date: 7 August 2017
NRAS-mutant melanoma: current challenges and future prospect
Muñoz-Couselo E, Zamora Adelantado E, Ortiz C, Soberino García J, Perez-Garcia J
OncoTargets and Therapy 2017, 10:3941-3947
Published Date: 8 August 2017
Bystander signaling via oxidative metabolism
Sawal HA, Asghar K, Bureik M, Jalal N
OncoTargets and Therapy 2017, 10:3925-3940
Published Date: 4 August 2017
Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer
Wu CN, Chuang HC, Lin YT, Fang FM, Li SH, Chien CY
OncoTargets and Therapy 2017, 10:3917-3924
Published Date: 4 August 2017
Clinicopathological and prognostic significance of circulating tumor cells in patients with head and neck cancer: a meta-analysis
Sun T, Zou K, Yuan Z, Yang C, Lin X, Xiong B
OncoTargets and Therapy 2017, 10:3907-3916
Published Date: 4 August 2017
RETRACTED ARTICLE: microRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer
Zhou Y, Li R, Yu H, Wang R, Shen Z
OncoTargets and Therapy 2017, 10:3893-3905
Published Date: 3 August 2017
SHP2 overexpression enhances the invasion and metastasis of ovarian cancer in vitro and in vivo
Hu ZQ, Li J, Gao Q, Wei S, Yang B
OncoTargets and Therapy 2017, 10:3881-3891
Published Date: 2 August 2017
A practical guide to the handling and administration of talimogene laherparepvec in Europe
Harrington KJ, Michielin O, Malvehy J, Pezzani Grüter I, Grove L, Frauchiger AL, Dummer R
OncoTargets and Therapy 2017, 10:3867-3880
Published Date: 2 August 2017
IGF2BP3 as a potential tissue marker for the diagnosis of esophageal high-grade intraepithelial neoplasia
Zhang JJ, Ji Q, Jiao CH, Ren LH, Zhao Y, Chen YF, Shi RH, Feng YD
OncoTargets and Therapy 2017, 10:3861-3866
Published Date: 1 August 2017
Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study
Lan XW, Xiao Y, Zou XB, Zhang XM, OuYang PY, Xie FY
OncoTargets and Therapy 2017, 10:3853-3860
Published Date: 1 August 2017
Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma
Liu W, Hu J, Zhou K, Chen F, Wang Z, Liao B, Dai Z, Cao Y, Fan J, Zhou J
OncoTargets and Therapy 2017, 10:3843-3851
Published Date: 1 August 2017
The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT
Sun HL, Ni JY, Jiang XY, Chen D, Chen YT, Xu LF
OncoTargets and Therapy 2017, 10:3835-3842
Published Date: 1 August 2017
Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma
Dong X, Guo W, Zhang S, Wu T, Sun Z, Yan S, Zheng S
OncoTargets and Therapy 2017, 10:3827-3833
Published Date: 31 July 2017
CD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinoma
Huang DW, Huang M, Lin XS, Huang Q
OncoTargets and Therapy 2017, 10:3817-3825
Published Date: 31 July 2017
Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer
Roviello G, Corona SP, Bonetta A, Cappelletti MR, Generali D
OncoTargets and Therapy 2017, 10:3811-3815
Published Date: 31 July 2017
The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
Sisay M, Mengistu G, Edessa D
OncoTargets and Therapy 2017, 10:3801-3810
Published Date: 27 July 2017
Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival
Peng JH, Li H, Ou QJ, Lin JZ, Wu XJ, Lu ZH, Yuan YF, Wan DS, Fang YJ, Pan ZZ
OncoTargets and Therapy 2017, 10:3789-3799
Published Date: 27 July 2017
Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
Wu M, Wanggou S, Li X, Liu Q, Xie Y
OncoTargets and Therapy 2017, 10:3781-3788
Published Date: 27 July 2017
MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects
Hua WF, Zhang A, Duan P, Zhu J, Zhao Y, He J, Zhang Z
OncoTargets and Therapy 2017, 10:3773-3780
Published Date: 27 July 2017
Volumetric modulated arc therapy for treatment of solid tumors: current insights
Macchia G, Deodato F, Cilla S, Cammelli S, Guido A, Ferioli M, Siepe G, Valentini V, Morganti AG, Ferrandina G
OncoTargets and Therapy 2017, 10:3755-3772
Published Date: 26 July 2017
KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity
Xie ZH, Yu J, Shang L, Zhu YQ, Hao JJ, Cai Y, Xu X, Zhang Y, Wang MR
OncoTargets and Therapy 2017, 10:3743-3754
Published Date: 26 July 2017
Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma
Shan Y, Chang T, Shi S, Tang M, Bao L, Li L, You B, You Y
OncoTargets and Therapy 2017, 10:3733-3741
Published Date: 24 July 2017
Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma
Liao X, Huang R, Liu X, Han C, Yu L, Wang SJ, Sun N, Li B, Ning X, Peng T
OncoTargets and Therapy 2017, 10:3719-3732
Published Date: 24 July 2017
The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies
Hu J, Wu C, Zhao X, Liu C
OncoTargets and Therapy 2017, 10:3709-3718
Published Date: 24 July 2017
Emerging role of nivolumab in the management of patients with non-small-cell lung cancer: current data and future perspectives
Feld E, Horn L
OncoTargets and Therapy 2017, 10:3697-3708
Published Date: 24 July 2017
miR-203 as a novel biomarker for the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
Ye H, Hao H, Wang J, Chen R, Huang Z
OncoTargets and Therapy 2017, 10:3685-3696
Published Date: 21 July 2017
Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study
Gao L, Li SH, Tian YX, Zhu QQ, Chen G, Pang YY, Hu XH
OncoTargets and Therapy 2017, 10:3667-3683
Published Date: 20 July 2017
Clinical targeting recombinant immunotoxins for cancer therapy
Li M, Liu ZS, Liu XL, Hui Q, Lu SY, Qu LL, Li YS, Zhou Y, Ren HL, Hu P
OncoTargets and Therapy 2017, 10:3645-3665
Published Date: 20 July 2017
Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia
Guo H, Zhang T, Wen X, Zhou JD, Ma J, An C, Zhang W, Xu Z, Lin J, Qian J
OncoTargets and Therapy 2017, 10:3635-3644
Published Date: 20 July 2017
Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis
Dai C, Wang M, Lu J, Dai Z, Lin S, Yang P, Tian T, Liu X, Min WL, Dai Z
OncoTargets and Therapy 2017, 10:3625-3634
Published Date: 21 July 2017
A systematic comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages between concurrent chemoradiotherapy and sequential chemotherapy
Qian M, Tao HM, Xu W, Ji HZ
OncoTargets and Therapy 2017, 10:3617-3623
Published Date: 20 July 2017
Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells
Barac A, Mitulovic G, Hallström S, Zehetmayer S, Grasl MC, Erovic BM
OncoTargets and Therapy 2017, 10:3607-3616
Published Date: 19 July 2017
Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis
Fan QW, Liu BR
OncoTargets and Therapy 2017, 10:3591-3606
Published Date: 19 July 2017
Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo
Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS
OncoTargets and Therapy 2017, 10:3579-3589
Published Date: 19 July 2017
Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia – role of blinatumomab
Queudeville M, Handgretinger R, Ebinger M
OncoTargets and Therapy 2017, 10:3567-3578
Published Date: 19 July 2017
The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy
Wang Y, Hu GF, Wang ZH
OncoTargets and Therapy 2017, 10:3557-3566
Published Date: 19 July 2017
Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer
Shen L, Wu X, Tan J, Gu M, Teng Y, Wang Z, Yue W
OncoTargets and Therapy 2017, 10:3545-3556
Published Date: 18 July 2017
Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer
Pan HW, Su HH, Hsu C, Huang GJ, Wu TT
OncoTargets and Therapy 2017, 10:3531-3543
Published Date: 17 July 2017
Circ-104916 is downregulated in gastric cancer and suppresses migration and invasion of gastric cancer cells
Li J, Zhen L, Zhang Y, Zhao L, Liu H, Cai D, Chen H, Yu J, Qi X, Li G
OncoTargets and Therapy 2017, 10:3521-3529
Published Date: 17 July 2017
Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors
Liu Z, Fan H, Li Y, Liu C
OncoTargets and Therapy 2017, 10:3515-3520
Published Date: 17 July 2017
Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
Heerma van Voss MR, Vesuna F, Bol GM, Meeldijk J, Raman A, Offerhaus GJ, Buerger H, Patel AH, van der Wall E, van Diest PJ, Raman V
OncoTargets and Therapy 2017, 10:3501-3513
Published Date: 17 July 2017
An evaluation of the clinical diagnostic value of contrast-enhanced ultrasound combined with contrast-enhanced computed tomography in space-occupying lesions of the kidney
Tian W, Lu JB, Jiao D, Cong ZB
OncoTargets and Therapy 2017, 10:3493-3499
Published Date: 14 July 2017
Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy
Zhou CC, Zhang J, Chen Y, Wang H, Hou JQ
OncoTargets and Therapy 2017, 10:3485-3491
Published Date: 14 July 2017
Association between polymorphisms in DNA repair gene XRCC1 and non-melanoma skin cancer risk: a meta-analysis
Wang L, Xu J, Duan B
OncoTargets and Therapy 2017, 10:3475-3483
Published Date: 13 July 2017
Ergosterol peroxide inhibits ovarian cancer cell growth through multiple pathways
Tan W, Pan M, Liu H, Tian H, Ye Q, Liu H
OncoTargets and Therapy 2017, 10:3467-3474
Published Date: 13 July 2017
PD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+PD-L1+ cancer cells
Kumar R, Yu F, Zhen YH, Li B, Wang J, Yang Y, Ge HX, Hu P, Xiu J
OncoTargets and Therapy 2017, 10:3453-3465
Published Date: 13 July 2017
Recent progress on the effects of microRNAs and natural products on tumor epithelial–mesenchymal transition
He SJ, Xiang CQ, Zhang Y, Lu XT, Chen HW, Xiong LX
OncoTargets and Therapy 2017, 10:3435-3451
Published Date: 12 July 2017
Evaluation of p53 gene expression and prognosis characteristics in uveal melanoma cases
Liu H, Zhou M
OncoTargets and Therapy 2017, 10:3429-3434
Published Date: 12 July 2017
RNA sequencing identifies gene expression profile changes associated with β-estradiol treatment in U2OS osteosarcoma cells
Chen B, Liu Z, Zhang J, Wang H, Yu B
OncoTargets and Therapy 2017, 10:3421-3427
Published Date: 11 July 2017
A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma
Liang HW, Ye ZH, Yin SY, Mo WJ, Wang HL, Zhao JC, Liang GM, Feng ZB, Chen G, Luo DZ
OncoTargets and Therapy 2017, 10:3405-3419
Published Date: 11 July 2017
ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma
Mao Y, Wu S
OncoTargets and Therapy 2017, 10:3399-3404
Published Date: 11 July 2017
Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis
Li W, Tao L, Zhang L, Xiu D
OncoTargets and Therapy 2017, 10:3391-3397
Published Date: 11 July 2017
Sex-related differences in clinicopathological features and survival of patients with primary urethral carcinoma: a population-based study
Wei Y, Wu YP, Xu N, Li XD, Chen SH, Cai H, Zheng QS, Xue XY
OncoTargets and Therapy 2017, 10:3381-3389
Published Date: 10 July 2017
The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia
Aberuyi N, Rahgozar S, Khosravi Dehaghi Z, Moafi A, Masotti A, Paolini A
OncoTargets and Therapy 2017, 10:3373-3380
Published Date: 10 July 2017
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M
OncoTargets and Therapy 2017, 10:3363-3372
Published Date: 10 July 2017
The long noncoding RNA, TINCR, functions as a competing endogenous RNA to regulate PDK1 expression by sponging miR-375 in gastric cancer
Chen ZL, Liu H, Yang HL, Gao YK, Zhang GW, Hu JJ
OncoTargets and Therapy 2017, 10:3353-3362
Published Date: 10 July 2017
Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma
Wang Z, Yang S, Lu H
OncoTargets and Therapy 2017, 10:3345-3351
Published Date: 7 July 2017
Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer
Guo Y, Shi JJ, Zhang J, Li HX, Liu B, Guo H
OncoTargets and Therapy 2017, 10:3337-3344
Published Date: 7 July 2017
Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinoma
Xue F, Hu C, He X
OncoTargets and Therapy 2017, 10:3329-3336
Published Date: 6 July 2017
Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells
Woitok M, Klose D, Di Fiore S, Richter W, Stein C, Gresch G, Grieger E, Barth S, Fischer R, Kolberg K, Niesen J
OncoTargets and Therapy 2017, 10:3313-3327
Published Date: 6 July 2017
Conventional real-time PCR-based detection of T790M using tumor tissue or blood in patients with EGFR TKI-resistant NSCLC
Wu Y, Tong R, Zhang Y, Hu B, Zheng K, Ding Z, Peng F, Gong Y, Liu Y, Lu Y
OncoTargets and Therapy 2017, 10:3307-3312
Published Date: 5 July 2017
Novel agents for the treatment of childhood leukemia: an update
Eryılmaz E, Canpolat C
OncoTargets and Therapy 2017, 10:3299-3306
Published Date: 4 July 2017
Reactive oxygen species mediate soft corals-derived sinuleptolide-induced antiproliferation and DNA damage in oral cancer cells
Chang YT, Huang C, Tang J, Liaw C, Li R, Liu J, Sheu J, Chang HW
OncoTargets and Therapy 2017, 10:3289-3297
Published Date: 4 July 2017
Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report
Yeo SG
OncoTargets and Therapy 2017, 10:3285-3288
Published Date: 4 July 2017
Therapeutic value of 3-D printing template-assisted 125I-seed implantation in the treatment of malignant liver tumors
Han T, Yang X, Xu Y, Zheng Z, Yan Y, Wang N
OncoTargets and Therapy 2017, 10:3277-3283
Published Date: 3 July 2017
The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases
Pan DH, Wen DY, Luo YH, Chen G, Yang H, Chen JQ, He Y
OncoTargets and Therapy 2017, 10:3261-3276
Published Date: 3 July 2017
Hedgehog signaling pathway in colorectal cancer: function, mechanism, and therapy
Wu C, Zhu X, Liu W, Ruan T, Tao K
OncoTargets and Therapy 2017, 10:3249-3259
Published Date: 30 June 2017
LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism
Ding G, Peng Z, Shang J, Kang Y, Ning HB, Mao CS
OncoTargets and Therapy 2017, 10:3241-3247
Published Date: 30 June 2017
Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02
Huang YD, Hong XL, Hu J, Lu Q
OncoTargets and Therapy 2017, 10:3233-3239
Published Date: 29 June 2017
Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles
Zhang X, Sun YY, Wang P, Yang CF, Li SW
OncoTargets and Therapy 2017, 10:3225-3232
Published Date: 29 June 2017
CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells
Wang M, Lin T, Wang YC, Gao S, Yang ZY, Hong X, Chen GY
OncoTargets and Therapy 2017, 10:3215-3224
Published Date: 29 June 2017
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction
Shimada M, Fukuda M, Fukuda M, Kitazaki T, Hashiguchi K, Ikeda T, Yamaguchi H, Nakatomi K, Ashizawa K, Mukae H
OncoTargets and Therapy 2017, 10:3211-3214
Published Date: 29 June 2017
Association of estrogen receptor α PvuII and XbaI polymorphisms with prostate cancer susceptibility and risk stratification: a meta-analysis from case-control studies
Zhao YN, Zheng X, Zhang LJ, Hu Q, Guo YT, Jiang H, Shi SN, Zhang X
OncoTargets and Therapy 2017, 10:3203-3210
Published Date: 29 June 2017
The effect of circulating miR-223 on surveillance of different cancers: a meta-analysis
Zhang YF, Lin JB, Huang WJ, Cao Y, Liu Y, Wang TQ, Zhong WY, Wang DL, Mao RR, Chen XL
OncoTargets and Therapy 2017, 10:3193-3201
Published Date: 28 June 2017
Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report
Zhu Y, Liao X, Wang W, Xu C, Zhuang W, Zhong L, Du K, Chen Y, Chen G, Fang M
OncoTargets and Therapy 2017, 10:3187-3192
Published Date: 27 June 2017
Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
Yao JC, Chan JA, Mita AC, Kundu MG, Hermosillo Reséndiz K, Hu K, Ravichandran S, Strosberg JR, Wolin EM
OncoTargets and Therapy 2017, 10:3177-3186
Published Date: 27 June 2017
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
Cymbaluk-Ploska A, Chudecka-Głaz A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Surowiec A, Menkiszak J
OncoTargets and Therapy 2017, 10:3169-3175
Published Date: 27 June 2017
Optimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of published randomized trials
Li C, Xiang A, Chen X, Yin K, Lu J, Yin W
OncoTargets and Therapy 2017, 10:3155-3168
Published Date: 27 June 2017
Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer
Song S, Li C, Li S, Gao H, Lan X, Xue Y
OncoTargets and Therapy 2017, 10:3145-3154
Published Date: 26 June 2017
Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo
Kuang Y, Lu F, Guo J, Xu H, Wang Q, Xu C, Zeng L, Yi S
OncoTargets and Therapy 2017, 10:3131-3144
Published Date: 26 June 2017
The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis
Zhang X, Yin X, Shen P, Sun G, Yang Y, Liu J, Chen N, Zeng H
OncoTargets and Therapy 2017, 10:3123-3130
Published Date: 22 June 2017
Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations
Song X, Wang Z
OncoTargets and Therapy 2017, 10:3119-3122
Published Date: 22 June 2017
Plasma fibrinogen and serum albumin levels (FA score) act as a promising prognostic indicator in non-small cell lung cancer
Chen P, Wang C, Cheng B, Nesa EU, Liu Y, Jia Y, Qu Y, Jiang Z, Han J, Cheng Y
OncoTargets and Therapy 2017, 10:3107-3118
Published Date: 21 June 2017
Comprehensive analysis of differential co-expression patterns reveal transcriptional dysregulation mechanism and identify novel prognostic lncRNAs in esophageal squamous cell carcinoma
Li Z, Yao Q, Zhao S, Wang Y, Li Y, Wang Z
OncoTargets and Therapy 2017, 10:3095-3105
Published Date: 21 June 2017
Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis
Zhang Y, Xu X, Chen Z, Zhao Z
OncoTargets and Therapy 2017, 10:3083-3093
Published Date: 20 June 2017
Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy
Bai Y, Wu HW, Ma X, Liu Y, Zhang YH
OncoTargets and Therapy 2017, 10:3071-3081
Published Date: 19 June 2017
The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis
Xu H, Ma Y, Deng F, Ju W, Sun X, Wang H
OncoTargets and Therapy 2017, 10:3059-3070
Published Date: 19 June 2017
Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma
Aigner KR, Selak E, Gailhofer S
OncoTargets and Therapy 2017, 10:3049-3057
Published Date: 19 June 2017
Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma
Ni W, Song E, Gong M, Li Y, Yao J, An R
OncoTargets and Therapy 2017, 10:3039-3047
Published Date: 19 June 2017
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
Dockery LE, Gunderson CC, Moore KN
OncoTargets and Therapy 2017, 10:3029-3037
Published Date: 19 June 2017
Identification of key genes and molecular mechanisms associated with dedifferentiated liposarcoma based on bioinformatic methods
Yu H, Pei D, Chen L, Zhou X, Zhu H
OncoTargets and Therapy 2017, 10:3017-3027
Published Date: 16 June 2017
Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts
De Tursi M, Zilli M, Carella C, Auriemma M, Lisco MN, Di Nicola M, Di Martino G, Natoli C, Amerio P
OncoTargets and Therapy 2017, 10:3007-3015
Published Date: 16 June 2017
Hepatic artery-infusion chemotherapy improved survival of hepatocellular carcinoma after radical hepatectomy
Feng M, Tang C, Feng W, Bao Y, Zheng Y, Shen J
OncoTargets and Therapy 2017, 10:3001-3005
Published Date: 14 June 2017
Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells
Yang Y, Yin W, Wu FY, Fan J
OncoTargets and Therapy 2017, 10:2993-2999
Published Date: 14 June 2017
Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors
Chang H, Kim JS, Choi YJ, Cho J, Woo J, Kim A, Kim JS, Kang EJ
OncoTargets and Therapy 2017, 10:2983-2992
Published Date: 13 June 2017
Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials
Liu YY, Kou CG, Su YY, Zhang YY, You YY, Zhang LL, Wang MH, Fu YL, Ren XJ, Yang YM
OncoTargets and Therapy 2017, 10:2971-2981
Published Date: 13 June 2017
Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy
de Groot S, Gelderblom H, Fiocco M, Bovée JVMG, van der Hoeven JJM, Pijl H, Kroep JR
OncoTargets and Therapy 2017, 10:2963-2970
Published Date: 13 June 2017
Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis
Yang B, Yan X, Liu L, Jiang C, Hou S
OncoTargets and Therapy 2017, 10:2951-2961
Published Date: 13 June 2017
Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
Kan HC, Hou CP, Lin YH, Tsui KH, Chang PL, Chen CL
OncoTargets and Therapy 2017, 10:2943-2949
Published Date: 12 June 2017
WWC3 downregulation correlates with poor prognosis and inhibition of Hippo signaling in human gastric cancer
Hou J, Zhou J
OncoTargets and Therapy 2017, 10:2931-2942
Published Date: 12 June 2017
Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma
Zhang J, Zhang G, Hu P, Deng G, Liu Q, Qiao L, Luo H, Zhang J
OncoTargets and Therapy 2017, 10:2923-2930
Published Date: 9 June 2017
Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
Chen X, Zhu X, Liang Z, Li L, Qu S, Chen K, Pan X
OncoTargets and Therapy 2017, 10:2909-2921
Published Date: 9 June 2017
Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
Noronha V, Choughule A, Patil VM, Joshi A, Kumar R, Susan Joy Philip D, Banavali S, Dutt A, Prabhash K
OncoTargets and Therapy 2017, 10:2903-2908
Published Date: 9 June 2017
The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis
Hu Z, Yang Y, Zhao Y, Huang Y
OncoTargets and Therapy 2017, 10:2893-2901
Published Date: 9 June 2017
Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
Li M, Yang X, Chen Y, Yang X, Dai X, Sun F, Zhang L, Zhan C, Feng M, Wang Q
OncoTargets and Therapy 2017, 10:2885-2892
Published Date: 7 June 2017
Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma
Xu Y, Jiang X, Cui Y
OncoTargets and Therapy 2017, 10:2873-2883
Published Date: 6 June 2017
PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy
Liu H, Zhang L, Zhang X, Cui Z
OncoTargets and Therapy 2017, 10:2865-2871
Published Date: 6 June 2017
Prognostic value of high IMP3 expression in solid tumors: a meta-analysis
Chen L, Xie Y, Li X, Gu L, Gao Y, Tang L, Chen J, Zhang X
OncoTargets and Therapy 2017, 10:2849-2863
Published Date: 6 June 2017
Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma
Bai X, Li Y, Zhang H, Wang F, He H, Yao J, Liu L, Li S
OncoTargets and Therapy 2017, 10:2837-2847
Published Date: 2 June 2017
Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction]
Yu L, Wang XL, Zhu D, Ding W, Wang L, Zhang C, Jiang X, Shen H, Liao S, Ma D, Hu Z, Wang H
OncoTargets and Therapy 2017, 10:2835-2836
Published Date: 2 June 2017
SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma
Huang W, Huang H, Wang L, Hu J, Song W
OncoTargets and Therapy 2017, 10:2825-2833
Published Date: 2 June 2017
Letter to the editor regarding the article “Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis”
Yu H, Wang P, Zhang X
OncoTargets and Therapy 2017, 10:2823-2824
Published Date: 6 June 2017
MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2
Wu MH, Ye XX, Wang SC, Li QH, Lai YX, Yi YM
OncoTargets and Therapy 2017, 10:2815-2822
Published Date: 2 June 2017
Panel of seven long noncoding RNA as a candidate prognostic biomarker for ovarian cancer
Zhan XH, Dong C, Liu G, Li YX, Liu L
OncoTargets and Therapy 2017, 10:2805-2813
Published Date: 1 June 2017
Silencing of AQP3 induces apoptosis of gastric cancer cells via downregulation of glycerol intake and downstream inhibition of lipogenesis and autophagy
Chen L, Li Z, Zhang Q, Wei S, Li B, Zhang X, Zhang L, Li Q, Xu H, Xu Z
OncoTargets and Therapy 2017, 10:2791-2804
Published Date: 1 June 2017
The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma
Wang X, Wang S, Li X, Jin S, Xiong F, Wang X
OncoTargets and Therapy 2017, 10:2781-2789
Published Date: 31 May 2017
Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum]
Ye T, Su J, Huang C, Yu D, Dai S, Huang X, Chen B, Zhou M
OncoTargets and Therapy 2017, 10:2779-2780
Published Date: 31 May 2017
The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism
Chen L, Sun L, Dong L, Cui P, Xia Z, Li C, Zhu Y
OncoTargets and Therapy 2017, 10:2769-2778
Published Date: 30 May 2017
Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study
Wu J, Li A, Yang J, Lu Y, Li J
OncoTargets and Therapy 2017, 10:2761-2768
Published Date: 29 May 2017
Pretreatment combination of platelet counts and neutrophil–lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy
Lin YH, Chang KP, Lin YS, Chang TS
OncoTargets and Therapy 2017, 10:2751-2760
Published Date: 26 May 2017
Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective study
Yuan G, Chen J, Wu D, Gao C
OncoTargets and Therapy 2017, 10:2745-2750
Published Date: 26 May 2017
Overexpression of ecotropic viral integration site-1 is a prognostic factor of lung squamous cell cancer
Xu X, Liu S, Ji X
OncoTargets and Therapy 2017, 10:2739-2744
Published Date: 26 May 2017
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis [Corrigendum]
Xia S, Wang C, Postma EL, Yang Y, Ni X, Zhan W
OncoTargets and Therapy 2017, 10:2737-2738
Published Date: 29 May 2017
The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma
Song G, Jing W, Xue S, Guo H, Yu J
OncoTargets and Therapy 2017, 10:2729-2736
Published Date: 25 May 2017
Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma
Kwon NS, Kim DS, Yun HY
OncoTargets and Therapy 2017, 10:2721-2728
Published Date: 24 May 2017
miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4
Hu H, Wang G, Li C
OncoTargets and Therapy 2017, 10:2711-2720
Published Date: 23 May 2017
MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway
Liu H, Pan Y, Han X, Liu J, Li R
OncoTargets and Therapy 2017, 10:2701-2709
Published Date: 23 May 2017
Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials
Veettil SK, Teerawattanapong N, Ching SM, Lim KG, Saokaew S, Phisalprapa P, Chaiyakunapruk N
OncoTargets and Therapy 2017, 10:2689-2700
Published Date: 23 May 2017
Ezh2, a novel target in detection and therapy of breast cancer
Pourakbar S, Pluard TJ, Accurso AD, Farassati F
OncoTargets and Therapy 2017, 10:2685-2687
Published Date: 22 May 2017
Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer
Shao Y, Zhu W, Da J, Xu M, Wang Y, Zhou J, Wang Z
OncoTargets and Therapy 2017, 10:2675-2683
Published Date: 22 May 2017
Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer
Mearini E, Poli G, Cochetti G, Boni A, Egidi MG, Brancorsini S
OncoTargets and Therapy 2017, 10:2665-2673
Published Date: 22 May 2017
The prognostic value of neutrophil–lymphocyte ratio is superior to derived neutrophil–lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up
Jin H, Sun J, Zhu K, Liu X, Zhang Q, Shen Q, Gao Y, Yu J
OncoTargets and Therapy 2017, 10:2655-2664
Published Date: 22 May 2017
Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation
Pang X, Li Q, Ma Z, Shi Y, Ma Y, Li X, Cui W, Zhang W
OncoTargets and Therapy 2017, 10:2645-2654
Published Date: 19 May 2017
The novel long noncoding RNA RP11–357H14.17 acts as an oncogene by promoting cell proliferation and invasion in diffuse-type gastric cancer
Yang B, Luo TH, Zhang MJ, Lu ZM, Xue XC, Fang GN
OncoTargets and Therapy 2017, 10:2635-2643
Published Date: 18 May 2017
FOLFOX regimen plus dendritic cells–cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis
Liu Y, Zheng Z, Zhang QX, Zhou XL, Feng YK, Yan AQ
OncoTargets and Therapy 2017, 10:2621-2633
Published Date: 18 May 2017
RNA-binding protein HuR promotes bladder cancer progression by competitively binding to the long noncoding HOTAIR with miR-1
Yu DP, Zhang C, Gui JQ
OncoTargets and Therapy 2017, 10:2609-2619
Published Date: 17 May 2017
Holliday junction–recognizing protein promotes cell proliferation and correlates with unfavorable clinical outcome of hepatocellular carcinoma
Hu B, Wang Q, Wang Y, Chen J, Li P, Han M
OncoTargets and Therapy 2017, 10:2601-2607
Published Date: 17 May 2017
Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study
Sun Y, Wang Y, Han S, Xing B, Li H, Zhu Y, Zhou S, Wang X, Xu J, Tao R
OncoTargets and Therapy 2017, 10:2595-2600
Published Date: 17 May 2017
The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia
Meier-Stephenson V, Riemer J, Narendran A
OncoTargets and Therapy 2017, 10:2581-2593
Published Date: 16 May 2017
Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
Chen L, Zuo YJ, Zhu LH, Zhang YX, Li S, Ma F, Han Y, Song HJ, Xue YW
OncoTargets and Therapy 2017, 10:2569-2580
Published Date: 17 May 2017
Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
Du E, Wang L, Li C, Zhang C, Qu Y, Liu R, Xu Y, Yang K, Zhang Z
OncoTargets and Therapy 2017, 10:2561-2567
Published Date: 15 May 2017
Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients
Tang H, Wu Y, Qin Y, Wang H, Jia Y, Yang S, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:2553-2560
Published Date: 15 May 2017
Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer
Hollis RL, Churchman M, Gourley C
OncoTargets and Therapy 2017, 10:2539-2551
Published Date: 11 May 2017
RETRACTED ARTICLE: MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein
Zhou S, Cui Y, Yu D, Liang J, Zhang M, Ye W
OncoTargets and Therapy 2017, 10:2527-2538
Published Date: 11 May 2017
New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib
Hirsh V
OncoTargets and Therapy 2017, 10:2513-2526
Published Date: 11 May 2017
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives [Corrigendum]
McCulloch D, Brown C, Iland H
OncoTargets and Therapy 2017, 10:2511-2512
Published Date: 8 May 2017
Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma
Zhong D, Cen H
OncoTargets and Therapy 2017, 10:2501-2509
Published Date: 8 May 2017
Clinicopathological significance of p14ARF expression in lung cancer: a meta-analysis
Wang F, Li H, Long J, Ye S
OncoTargets and Therapy 2017, 10:2491-2499
Published Date: 8 May 2017
Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment
Shi Y, Jia R, Fan X
OncoTargets and Therapy 2017, 10:2483-2489
Published Date: 8 May 2017
Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis
Batson S, Mitchell SA, Windisch R, Damonte E, Munk VC, Reguart N
OncoTargets and Therapy 2017, 10:2473-2482
Published Date: 5 May 2017
Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells
Liu Q, Liu H, Cheng HP, Li Y, Li XD, Zhu CY
OncoTargets and Therapy 2017, 10:2461-2471
Published Date: 5 May 2017
A retrospective study on the prognostic value of preoperative neutrophil/lymphocyte ratio in patients with primary small-cell carcinoma of the esophagus
Wang Y, Liu JF
OncoTargets and Therapy 2017, 10:2453-2459
Published Date: 5 May 2017
An isolated unusual digit metastasis from esophageal carcinoma: a case report
Chen Y, Tang W, Xiao H, Chen J, Zhao H, Shi J
OncoTargets and Therapy 2017, 10:2449-2452
Published Date: 9 May 2017
Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide
Haq S, Samuel V, Haxho F, Akasov R, Leko M, Burov SV, Markvicheva E, Szewczuk MR
OncoTargets and Therapy 2017, 10:2427-2447
Published Date: 4 May 2017
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M
OncoTargets and Therapy 2017, 10:2425-2426
Published Date: 4 May 2017
Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response
Sun WW, Xu ZH, Lian P, Gao BL, Hu JA
OncoTargets and Therapy 2017, 10:2413-2424
Published Date: 4 May 2017
FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer [Retraction]
Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W
OncoTargets and Therapy 2017, 10:2411-2412
Published Date: 3 May 2017
The voice quality after laser surgery versus radiotherapy of T1a glottic carcinoma: systematic review and meta-analysis
Huang GJ, Luo MS, Zhang JX, Liu HB
OncoTargets and Therapy 2017, 10:2403-2410
Published Date: 3 May 2017
Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes
Heinrich B, Klein J, Delic M, Goepfert K, Engel V, Geberzahn L, Lusky M, Erbs P, Preville X, Moehler M
OncoTargets and Therapy 2017, 10:2389-2401
Published Date: 2 May 2017
Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells
Feng S, Wang Y, Zhang R, Yang G, Liang Z, Wang Z, Zhang G
OncoTargets and Therapy 2017, 10:2377-2388
Published Date: 2 May 2017
Knockdown of a DIS3L2 promoter upstream long noncoding RNA (AC105461.1) enhances colorectal cancer stem cell properties in vitro by down-regulating DIS3L2
Liu W, Yu Q, Ma J, Cheng Y, Zhang H, Luo W, Yao J, Zhang H
OncoTargets and Therapy 2017, 10:2367-2376
Published Date: 2 May 2017
Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches [Corrigendum]
Pathan AAK, Panthi B, Khan Z, Koppula PR, Alanazi M, Sachchidanand, Parine NR, Chourasia M
OncoTargets and Therapy 2017, 10:2365-2366
Published Date: 28 April 2017
Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
Ilcus C, Bagacean C, Tempescul A, Popescu C, Parvu A, Cenariu M, Bocsan C, Zdrenghea M
OncoTargets and Therapy 2017, 10:2349-2363
Published Date: 28 April 2017
Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
Hu Y, Zang J, Qin X, Yan D, Cao H, Zhou L, Ni J, Yu S, Wu J, Feng JF
OncoTargets and Therapy 2017, 10:2341-2348
Published Date: 28 April 2017
The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
Bai H, Xiong L, Han B
OncoTargets and Therapy 2017, 10:2335-2340
Published Date: 27 April 2017
No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations
Semlali A, Almutairi M, Parine NR, Al Amri A, Shaik JP, Al Naeem A, Abdulla Ajaj S, Rouabhia M, Alanazi MS
OncoTargets and Therapy 2017, 10:2325-2333
Published Date: 27 April 2017
B-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancer [Corrigendum]
Zhao Q, Gui T, Qian Q, Li L, Shen K
OncoTargets and Therapy 2017, 10:2323-2324
Published Date: 27 April 2017
Identification of potential biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma by bioinformatics analysis
Yang B, Chen Z, Huang Y, Han G, Li W
OncoTargets and Therapy 2017, 10:2315-2321
Published Date: 26 April 2017
Maintenance therapy with all-trans retinoic acid and arsenic trioxide improves relapse-free survival in adults with low- to intermediate-risk acute promyelocytic leukemia who have achieved complete remission after consolidation therapy
Liang B, Zheng ZY, Shi YF, Chen JJ, Hu XD, Qian HL, Shen ZJ, Jiang SF, Yu K, Feng JH
OncoTargets and Therapy 2017, 10:2305-2313
Published Date: 26 April 2017
Role of CT scan in differentiating the type of colorectal cancer
Li ZH, You DY, Gao DP, Yang GJ, Dong XX, Zhang DF, Ding YY
OncoTargets and Therapy 2017, 10:2297-2303
Published Date: 26 April 2017
Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report
Peng Y, Cui H, Liu Z, Liu D, Liu F, Song Y, Duan H, Qiu Y, Li Q
OncoTargets and Therapy 2017, 10:2289-2295
Published Date: 26 April 2017
Treatment-related severe and fatal adverse events with molecular targeted agents in the treatment of advanced gastric cancer: a meta-analysis
Wang L, Liu Y, Zhou W, Li W
OncoTargets and Therapy 2017, 10:2281-2287
Published Date: 26 April 2017
Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs
Liu Y, Sun L, Xiong Z, Sun X, Zhang S, Ma J, Han C
OncoTargets and Therapy 2017, 10:2267-2279
Published Date: 24 April 2017
Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection
Leng KM, Liu YP, Wang ZD, Zhong XY, Liao GQ, Kang PC, Cui YF, Jiang XM
OncoTargets and Therapy 2017, 10:2257-2266
Published Date: 21 April 2017
Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer
Ma J, Yang Y, Wang Y, Zhang X, Gu X, Wang Z
OncoTargets and Therapy 2017, 10:2249-2256
Published Date: 21 April 2017
PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro
Cui W, Zheng S, Liu Z, Wang W, Cai Y, Bi R, Cao B, Zhou X
OncoTargets and Therapy 2017, 10:2239-2247
Published Date: 20 April 2017
Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer
Zhang J, Liu Q, Qiao L, Hu P, Deng G, Liang N, Xie J, Luo H, Zhang J
OncoTargets and Therapy 2017, 10:2227-2237
Published Date: 20 April 2017
NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo
Lian JP, Lin D, Xie X, Xu Y, Xu L, Meng L, Zhu Y
OncoTargets and Therapy 2017, 10:2219-2226
Published Date: 19 April 2017
Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer
Huang BT, Wu LL, Guo LJ, Xu LY, Huang RH, Lin PX, Chen JZ, Li DR, Chen CZ
OncoTargets and Therapy 2017, 10:2209-2217
Published Date: 19 April 2017
Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients
You J, Zhang H, Shen Y, Chen C, Liu W, Zheng M, Van Poucke S, Guo G, Huang Z
OncoTargets and Therapy 2017, 10:2199-2208
Published Date: 18 April 2017
Allergic conditions are not associated with the risk of non-Hodgkin’s lymphoma or Hodgkin’s lymphoma: a systematic review and meta-analysis
Yang J, Xu H, Liang X, Lv S, Lin B, Jia Y
OncoTargets and Therapy 2017, 10:2189-2198
Published Date: 18 April 2017
Novel insights into circular RNAs in clinical application of carcinomas
Rong D, Tang W, Li Z, Zhou J, Shi J, Wang H, Cao H
OncoTargets and Therapy 2017, 10:2183-2188
Published Date: 18 April 2017
Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
Luo D, Chen W, Tian Y, Li J, Xu X, Chen C, Li F
OncoTargets and Therapy 2017, 10:2173-2181
Published Date: 18 April 2017
Monosomal karyotype in myeloid neoplasias: a literature review
Anelli L, Pasciolla C, Zagaria A, Specchia G, Albano F
OncoTargets and Therapy 2017, 10:2163-2171
Published Date: 20 April 2017
Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection
Liu J, Chen S, Geng Q, Liu X, Kong P, Zhan Y, Xu D
OncoTargets and Therapy 2017, 10:2155-2162
Published Date: 13 April 2017
Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy
Liu Q, Hu P, Deng G, Zhang J, Liang N, Xie J, Qiao L, Luo H, Zhang J
OncoTargets and Therapy 2017, 10:2147-2154
Published Date: 12 April 2017
Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cells
Gan S, Ye J, Wang L, Qu F, Chu C, Tian Y, Yang W, Cui X
OncoTargets and Therapy 2017, 10:2139-2146
Published Date: 12 April 2017
miR-762 can negatively regulate menin in ovarian cancer
Hou R, Yang Z, Wang S, Chu D, Liu Q, Liu J, Jiang L
OncoTargets and Therapy 2017, 10:2127-2137
Published Date: 12 April 2017
A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/AkT/MTOR signaling pathway
Zhao L, Li C, Liu F, Zhao Y, Liu J, Hua Y, Liu J, Huang J, Ge C
OncoTargets and Therapy 2017, 10:2115-2126
Published Date: 12 April 2017
Gastric cancer, nutritional status, and outcome
Liu X, Qiu H, Kong P, Zhou Z, Sun X
OncoTargets and Therapy 2017, 10:2107-2114
Published Date: 12 April 2017
Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
Wagner LM, Adams VR
OncoTargets and Therapy 2017, 10:2097-2106
Published Date: 12 April 2017
Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis
Wang X, Miao C, Chen Z, Li W, Yuan S, Yu J, Hu X
OncoTargets and Therapy 2017, 10:2087-2095
Published Date: 11 April 2017
Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors
Rossmeisl JH, Hall-Manning K, Robertson JL, King JN, Davalos RV, Debinski W, Elankumaran S
OncoTargets and Therapy 2017, 10:2077-2085
Published Date: 12 April 2017
Therapeutic outcome of nasopharyngeal carcinoma with cranial nerve palsy: a single institution experience of 104 patients
Huang CC, Fang FM, Chen HC, Hsu HC, Huang TL, Su YL, Chang YC
OncoTargets and Therapy 2017, 10:2069-2075
Published Date: 10 April 2017
The role of KPNβ1 in neuro-oncology
Lilley M, Farassati F
OncoTargets and Therapy 2017, 10:2067-2068
Published Date: 10 April 2017
Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date
Levin PA, Dowell JE
OncoTargets and Therapy 2017, 10:2057-2066
Published Date: 7 April 2017
Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7
Tang W, Ji M, He G, Yang L, Niu Z, Jian M, Wei Y, Ren L, Xu J
OncoTargets and Therapy 2017, 10:2045-2056
Published Date: 7 April 2017
Patient considerations in metastatic colorectal cancer – role of panitumumab
Rogers JE
OncoTargets and Therapy 2017, 10:2033-2044
Published Date: 7 April 2017
Expression and significance of GRHL2 in esophageal cancer
Shao CC, Ji CS, Wang XQ, Hu B
OncoTargets and Therapy 2017, 10:2025-2031
Published Date: 7 April 2017
REG3A promotes the proliferation, migration, and invasion of gastric cancer cells
Chen ZF, Huang ZM, Xue HB, Lin XQ, Chen RP, Chen MJ, Jin RF
OncoTargets and Therapy 2017, 10:2017-2023
Published Date: 6 April 2017
Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review
Chen F, Pu F
OncoTargets and Therapy 2017, 10:2009-2016
Published Date: 6 April 2017
Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients
Chen J, Li H, Pang RL, Huang J
OncoTargets and Therapy 2017, 10:2003-2007
Published Date: 6 April 2017
Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer
Yan CS, Jiang Y, Wan YC, Zhang L, Liu JH, Zhou SL, Cheng WJ
OncoTargets and Therapy 2017, 10:1993-2002
Published Date: 6 April 2017
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A
OncoTargets and Therapy 2017, 10:1983-1992
Published Date: 6 April 2017
Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation
Andersen MN, Ludvigsen M, Abildgaard N, Petruskevicius I, Hjortebjerg R, Bjerre M, Honoré B, Møller HJ, Andersen NF
OncoTargets and Therapy 2017, 10:1977-1982
Published Date: 4 April 2017
HSD17B12 gene rs11037575 C>T polymorphism confers neuroblastoma susceptibility in a Southern Chinese population
Zhang ZR, Zou Y, Zhu JH, Zhang RZ, Yang TY, Wang FH, Xia HM, He J, Feng ZC
OncoTargets and Therapy 2017, 10:1969-1975
Published Date: 4 April 2017
Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
Sun S, Yu H, Wang H, Zhao X, Zhao X, Wu X, Qiao J, Chang J, Wang J
OncoTargets and Therapy 2017, 10:1955-1967
Published Date: 3 April 2017
Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer
Yan Y, Zhou K, Wang L, Wang F, Chen X, Fan Q
OncoTargets and Therapy 2017, 10:1947-1954
Published Date: 3 April 2017
Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line
Attar R, Cincin ZB, Bireller ES, Cakmakoglu B
OncoTargets and Therapy 2017, 10:1941-1946
Published Date: 31 March 2017
FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer
Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W
OncoTargets and Therapy 2017, 10:1933-1939
Published Date: 30 March 2017
Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane
Townsend MH, Anderson MD, Weagel EG, Velazquez EJ, Weber KS, Robison RA, O'Neill KL
OncoTargets and Therapy 2017, 10:1921-1932
Published Date: 30 March 2017
Expression of SHP-1 and SOCS6 in patients with acute leukemia and their clinical implication
Liu J, Zheng Y, Gao J, Zhu G, Gao K, Zhang W, Shi F, Shi Q
OncoTargets and Therapy 2017, 10:1915-1920
Published Date: 29 March 2017
Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia
Khan M, Gibbons JL, Ferrajoli A
OncoTargets and Therapy 2017, 10:1909-1914
Published Date: 29 March 2017
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
Liu Y, Mu Y, Zhang A, Ren SD, Wang WH, Xie JP, Zhang YX, Zhou CH
OncoTargets and Therapy 2017, 10:1897-1908
Published Date: 29 March 2017
Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis
Halpern N, Goldberg Y, Kadouri L, Duvdevani M, Hamburger T, Peretz T, Hubert A
OncoTargets and Therapy 2017, 10:1889-1896
Published Date: 29 March 2017
Genetic variants and increased risk of meningioma: an updated meta-analysis
Han X, Wang W, Wang L, Wang X, Li G
OncoTargets and Therapy 2017, 10:1875-1888
Published Date: 28 March 2017
DNMT1 regulates human endometrial carcinoma cell proliferation
Wang X, Li B
OncoTargets and Therapy 2017, 10:1865-1873
Published Date: 29 March 2017
EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?
Joshi A, Zanwar S, Noronha V, Patil VM, Chougule A, Kumar R, Janu A, Mahajan A, Kapoor A, Prabhash K
OncoTargets and Therapy 2017, 10:1859-1863
Published Date: 28 March 2017
Pancreatic solitary fibrous tumor in a toddler managed by pancreaticoduodenectomy: a case report and review of the literature
Sheng Q, Xu W, Liu J, Shen B, Deng X, Wu Y, Wu W, Yu S, Wang X, Lv Z
OncoTargets and Therapy 2017, 10:1853-1858
Published Date: 27 March 2017
Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis
Wu J, Cheng G, Zhang C, Zheng Y, Xu H, Yang H, Hua L
OncoTargets and Therapy 2017, 10:1843-1852
Published Date: 27 March 2017
Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial
Lazzari G, Terlizzi A, Della Vittoria Scarpati G, Perri F, De Chiara V, Turi B, Silvano G
OncoTargets and Therapy 2017, 10:1835-1842
Published Date: 24 March 2017
Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression
Xu X, Shen H, Zhu L, Lu J, Zhang L, Luo Z, Wu Y
OncoTargets and Therapy 2017, 10:1827-1834
Published Date: 23 March 2017
Salvage treatment with apatinib for advanced non-small-cell lung cancer
Song Z, Yu X, Lou G, Shi X, Zhang Y
OncoTargets and Therapy 2017, 10:1821-1825
Published Date: 23 March 2017
Role of Nrf2 signaling pathway in the radiation tolerance of patients with head and neck squamous cell carcinoma: an in vivo and in vitro study
Wang T, Hu P, Li B, Zhang J, Cheng Y, Liang Y
OncoTargets and Therapy 2017, 10:1809-1819
Published Date: 23 March 2017
Understanding the role of PD-L1/PD1 pathway blockade and autophagy in cancer therapy
Robainas M, Otano R, Bueno S, Ait-Oudhia S
OncoTargets and Therapy 2017, 10:1803-1807
Published Date: 23 March 2017
Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis
He H, Zhai X, Liu X, Zheng J, Zhai Y, Gao F, Chen Y, Lu J
OncoTargets and Therapy 2017, 10:1793-1801
Published Date: 23 March 2017
Focal adhesion kinases crucially regulate TGFβ-induced migration and invasion of bladder cancer cells via Src kinase and E-cadherin
Kong D, Chen F, Sima N
OncoTargets and Therapy 2017, 10:1783-1792
Published Date: 23 March 2017
Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis
Cui X, Zhang J, Lv J, Yan Y, Liu X, Wang J, Lv Y, Zhang J
OncoTargets and Therapy 2017, 10:1777-1781
Published Date: 23 March 2017
Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
Shi L, Zheng H, Hu W, Zhou B, Dai X, Zhang Y, Liu Z, Wu X, Zhao C, Liang G
OncoTargets and Therapy 2017, 10:1767-1776
Published Date: 23 March 2017
Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)
Saad N, Poudel A, Basnet A, Gajra A
OncoTargets and Therapy 2017, 10:1757-1766
Published Date: 22 March 2017
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis
Xia S, Wang C, Postma EL, Yang Y, Ni X, Zhan W
OncoTargets and Therapy 2017, 10:1743-1755
Published Date: 22 March 2017
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M
OncoTargets and Therapy 2017, 10:1735-1742
Published Date: 21 March 2017
The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis
Wang J, Shen CX, Fu Y, Yu T, Song J
OncoTargets and Therapy 2017, 10:1725-1734
Published Date: 21 March 2017
Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas
Ye ZH, Gao L, Wen DY, He Y, Pang YY, Chen G
OncoTargets and Therapy 2017, 10:1711-1723
Published Date: 21 March 2017
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]
Xu J, Liu X, Yang S, Zhang X, Shi Y
OncoTargets and Therapy 2017, 10:1709-1710
Published Date: 21 March 2017
Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum]
Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC
OncoTargets and Therapy 2017, 10:1707-1708
Published Date: 21 March 2017
Suppression of microRNA-629 enhances sensitivity of cervical cancer cells to 1′S-1′-acetoxychavicol acetate via regulating RSU1
Phuah NH, Azmi MN, Awang K, Nagoor NH
OncoTargets and Therapy 2017, 10:1695-1705
Published Date: 20 March 2017
Primary pancreatic lymphoma: two case reports and a literature review
Yu L, Chen Y, Xing L
OncoTargets and Therapy 2017, 10:1687-1694
Published Date: 20 March 2017
Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma
Ning X, Deng Y
OncoTargets and Therapy 2017, 10:1673-1686
Published Date: 20 March 2017
Role of cytokines and chemokines in alcohol-induced tumor promotion
Chen D, Zhang F, Ren H, Luo J, Wang S
OncoTargets and Therapy 2017, 10:1665-1671
Published Date: 17 March 2017
Human omental adipose-derived mesenchymal stem cell-conditioned medium alters the proteomic profile of epithelial ovarian cancer cell lines in vitro
Zhang YL, Dong WH, Wang JJ, Cai J, Wang ZH
OncoTargets and Therapy 2017, 10:1655-1663
Published Date: 17 March 2017
Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas
Jain S, Song R, Xie J
OncoTargets and Therapy 2017, 10:1645-1653
Published Date: 16 March 2017
Evaluation of efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma using magnetic resonance diffusion-weighted imaging
Wu X, Wang J, Ji J, Chen M, Song J
OncoTargets and Therapy 2017, 10:1637-1643
Published Date: 16 March 2017
MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro
Zhou K, Fan Y, Wu P, Duysenbi S, Feng Z, Du G, Zhang T
OncoTargets and Therapy 2017, 10:1625-1635
Published Date: 16 March 2017
CDKL1 promotes tumor proliferation and invasion in colorectal cancer
Qin C, Ren L, Ji M, Lv S, Wei Y, Zhu D, Lin Q, Xu P, Chang W, Xu J
OncoTargets and Therapy 2017, 10:1613-1624
Published Date: 16 March 2017
TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling
Dai Y, Duan H, Duan C, Zhu H, Zhou R, Pei H, Shen L
OncoTargets and Therapy 2017, 10:1603-1611
Published Date: 14 March 2017
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
McCulloch D, Brown C, Iland H
OncoTargets and Therapy 2017, 10:1585-1601
Published Date: 14 March 2017
SDF1-3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis
Zhang X, Fan Y, Li Z
OncoTargets and Therapy 2017, 10:1575-1583
Published Date: 14 March 2017
Mechanism of immune evasion in breast cancer
Wang M, Zhang C, Song Y, Wang Z, Wang Y, Luo F, Xu Y, Zhao Y, Wu Z, Xu Y
OncoTargets and Therapy 2017, 10:1561-1573
Published Date: 14 March 2017
Knockdown of IQGAP1 inhibits proliferation and epithelial–mesenchymal transition by Wnt/β-catenin pathway in thyroid cancer
Su D, Liu Y, Song T
OncoTargets and Therapy 2017, 10:1549-1559
Published Date: 13 March 2017
Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study
Yang J, Li S, Lv M, Wu Y, Chen Z, Shen Y, Wang B, Chen L, Yi M, Yang J
OncoTargets and Therapy 2017, 10:1535-1548
Published Date: 13 March 2017
Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma
Vatte C, Al Amri AM, Cyrus C, Chathoth S, Acharya S, Hashim TM, Al Ali Z, Alshreadah ST, Alsayyah A, Al-Ali AK
OncoTargets and Therapy 2017, 10:1527-1533
Published Date: 13 March 2017
Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report
Deng L, Wang Y, Lu W, Liu Q, Wu J, Jin J
OncoTargets and Therapy 2017, 10:1521-1525
Published Date: 13 March 2017
MTA1 promotes proliferation and invasion in human gastric cancer cells [Retraction]
Yao Y, Feng S, Xiao M, Li Y, Yang L, Gong J
OncoTargets and Therapy 2017, 10:1519-1520
Published Date: 10 March 2017
Adverse prognostic impact of TGFB1 T869C polymorphism in non-small-cell lung cancer
Sang Y, Bi X, Liu Y, Zhang W, Wang D
OncoTargets and Therapy 2017, 10:1513-1518
Published Date: 10 March 2017
Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells
Chen W, Zhao K, Miao C, Xu A, Zhang J, Zhu J, Su S, Wang Z
OncoTargets and Therapy 2017, 10:1503-1512
Published Date: 9 March 2017
Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
Aydin AM, Woldu SL, Hutchinson RC, Boegemann M, Bagrodia A, Lotan Y, Margulis V, Krabbe LM
OncoTargets and Therapy 2017, 10:1487-1502
Published Date: 9 March 2017
Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors
Guo W, Zheng YB, Xu B, Ma F, Li C, Zhang XQ, Wang Y, Chang XT
OncoTargets and Therapy 2017, 10:1475-1485
Published Date: 8 March 2017
Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors
Guo C, Chen X, Xiao W, Wang Q, Sun K, Wang Z
OncoTargets and Therapy 2017, 10:1465-1474
Published Date: 7 March 2017
Chronological changes in lung cancer surgery in a single Japanese institution
Nakamura H, Sakai H, Kimura H, Miyazawa T, Marushima H, Saji H
OncoTargets and Therapy 2017, 10:1459-1464
Published Date: 6 March 2017
Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
Sarri AJ, Dias R, Laurienzo CE, Gonçalves MCP, Dias DS, Moriguchi SM
OncoTargets and Therapy 2017, 10:1451-1457
Published Date: 6 March 2017
Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2017, 10:1441-1449
Published Date: 6 March 2017
GSTM1 polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis
Zhang F, Wu X, Niu J, Kang X, Cheng L, Lv Y, Wu M
OncoTargets and Therapy 2017, 10:1433-1440
Published Date: 6 March 2017
MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK
Chen P, Xu W, Luo Y, Zhang Y, He Y, Yang S, Yuan Z
OncoTargets and Therapy 2017, 10:1423-1431
Published Date: 6 March 2017
Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia
Koprivnikar J, McCloskey J, Faderl S
OncoTargets and Therapy 2017, 10:1413-1422
Published Date: 6 March 2017
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
Ali MA, Lacin S, Abdel-Wahab R, Uemura M, Hassan M, Rashid A, Duda DG, Kaseb AO
OncoTargets and Therapy 2017, 10:1403-1412
Published Date: 3 March 2017
HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition
Luan XR, Ma CJ, Wang P, Lou FL
OncoTargets and Therapy 2017, 10:1389-1402
Published Date: 3 March 2017
Arterial stiffness in hematologic malignancies
Mozos I, Borzak G, Caraba A, Mihaescu R
OncoTargets and Therapy 2017, 10:1381-1388
Published Date: 3 March 2017
The world of targeted therapies in kidney cancers: pitfalls, tips and tricks
Vallard A, Trone JC, Langrand-Escure J, Espenel S, Guy JB, Rancoule C, Xia YX, El Meddeb Hamrouni A, Ben Mrad M, Magné N
OncoTargets and Therapy 2017, 10:1375-1380
Published Date: 3 March 2017
Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
Qiao Y, Li J, Shi C, Wang W, Qu X, Xiong M, Sun Y, Li D, Zhao X, Zhang D
OncoTargets and Therapy 2017, 10:1363-1373
Published Date: 3 March 2017
MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3
He M, Xue Y
OncoTargets and Therapy 2017, 10:1353-1361
Published Date: 2 March 2017
125I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy：a comparison with best supportive care
Song J, Fan X, Zhao Z, Chen M, Chen W, Wu F, Zhang D, Chen L, Tu J, Ji J
OncoTargets and Therapy 2017, 10:1345-1352
Published Date: 2 March 2017
Evidence from a meta-analysis: is nivolumab neurotoxic in cancer patients?
Kong X, Kong Y
OncoTargets and Therapy 2017, 10:1335-1344
Published Date: 1 March 2017
Clarifying the molecular mechanism associated with carfilzomib resistance in human multiple myeloma using microarray gene expression profile and genetic interaction network
Zheng Z, Liu T, Zheng J, Hu J
OncoTargets and Therapy 2017, 10:1327-1334
Published Date: 1 March 2017
Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway
Li R, Dong T, Hu C, Lu J, Dai J, Liu P
OncoTargets and Therapy 2017, 10:1317-1325
Published Date: 28 February 2017
Downregulation of long noncoding RNA HOTAIRM1 promotes monocyte/dendritic cell differentiation through competitively binding to endogenous miR-3960
Xin J, Li J, Feng Y, Wang L, Zhang Y, Yang R
OncoTargets and Therapy 2017, 10:1307-1315
Published Date: 1 March 2017
Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study
Losem C, Koenigsmann M, Rudolph C
OncoTargets and Therapy 2017, 10:1295-1305
Published Date: 28 February 2017
Discrimination of serous cystadenoma from mucinous cystadenoma in the pancreas with contrast-enhanced ultrasonography: a prospective study in 61 patients
Sun Y, Zhou F, Liu F, Hu Y, Tan S, Liang P, Linghu EQ, Yu X
OncoTargets and Therapy 2017, 10:1285-1294
Published Date: 28 February 2017
Sequential treatment of tyrosine kinase inhibitor and platinum-based doublet chemotherapy on EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled clinical trials
Qiao L, Wang J, Long G, Jiang Y
OncoTargets and Therapy 2017, 10:1279-1284
Published Date: 28 February 2017
MicroRNA-194 modulates epithelial–mesenchymal transition in human colorectal cancer metastasis
Cai H, Chen X, Tang Y, Deng Y
OncoTargets and Therapy 2017, 10:1269-1278
Published Date: 28 February 2017
Arenobufagin activates p53 to trigger esophageal squamous cell carcinoma cell apoptosis in vitro and in vivo
Lv J, Lin S, Peng P, Cai C, Deng J, Wang M, Li X, Lin R, Lin Y, Fang A, Li Q
OncoTargets and Therapy 2017, 10:1261-1267
Published Date: 28 February 2017
Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis
Wang L, Yang D, Lv JY, Yu D, Xin SJ
OncoTargets and Therapy 2017, 10:1247-1260
Published Date: 27 February 2017
miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
Luan WK, Qian Y, Ni X, Bu XF, Xia Y, Wang JL, Ruan HR, Ma SJ, Xu B
OncoTargets and Therapy 2017, 10:1237-1246
Published Date: 27 February 2017
A new tumor suppressor lncRNA RP11-190D6.2 inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells
Tong W, Yang L, Yu Q, Yao J, He A
OncoTargets and Therapy 2017, 10:1227-1235
Published Date: 27 February 2017
The expression of aplysia ras homolog I (ARHI) and its inhibitory effect on cell biological behavior in esophageal squamous cell carcinoma
Mao Y, Han Y, Shi W
OncoTargets and Therapy 2017, 10:1217-1226
Published Date: 27 February 2017
Toll-like receptor-4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women
Semlali A, Jalouli M, Parine NR, Al Amri A, Arafah M, Al Naeem A, Abdullah Ajaj S, Rouabhia M, Alanazi MS
OncoTargets and Therapy 2017, 10:1207-1216
Published Date: 24 February 2017
Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort
Zhou G, Liu X, Wang X, Jin D, Chen Y, Li G, Li C, Fu D, Xu W, Wang X
OncoTargets and Therapy 2017, 10:1199-1206
Published Date: 24 February 2017
Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial–mesenchymal transition
Xu Y, Wang B, Zhang F, Wang A, Du X, Hu P, Zhu Y, Fang Z
OncoTargets and Therapy 2017, 10:1191-1198
Published Date: 24 February 2017
Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B-virus positive hepatocellular carcinoma after curative resection
Li G, Ji J, Yang F, Xu H, Bai Y
OncoTargets and Therapy 2017, 10:1181-1189
Published Date: 23 February 2017
Aberrant histone modification in CD19+ B cells of the patients with chronic lymphocytic leukemia
Zhou K, Zhang Q, Liu Y, Xiong Y, Wu S, Yang J, Zhou H, Liu X, Wei X, Song Y
OncoTargets and Therapy 2017, 10:1173-1179
Published Date: 23 February 2017
Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysis
Huang Y, Sun Y, Peng P, Zhu S, Sun W, Zhang P
OncoTargets and Therapy 2017, 10:1165-1172
Published Date: 23 February 2017
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
Recine F, Bongiovanni A, Riva N, Fausti V, De Vita A, Mercatali L, Liverani C, Miserocchi G, Amadori D, Ibrahim T
OncoTargets and Therapy 2017, 10:1155-1164
Published Date: 23 February 2017
Association between TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk in a Chinese population
Fu W, Zhuo Z, Jia W, Zhu J, Zhu S, Lin Z, Wang F, Xia H, He J, Liu G
OncoTargets and Therapy 2017, 10:1149-1154
Published Date: 23 February 2017
Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer
Nakamura S, Fukui T, Suzuki S, Takeda H, Watanabe K, Yoshioka T
OncoTargets and Therapy 2017, 10:1143-1147
Published Date: 23 February 2017
Intrahepatic cholangiocarcinoma: current perspectives
Buettner S, van Vugt JLA, IJzermans JNM, Groot Koerkamp B
OncoTargets and Therapy 2017, 10:1131-1142
Published Date: 22 February 2017
Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study
Zhao YX, Liu S, Hu YB, Ge YY, Lv DM
OncoTargets and Therapy 2017, 10:1123-1129
Published Date: 22 February 2017
miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8
Liu Y, Zhang B, Shi T, Qin H
OncoTargets and Therapy 2017, 10:1115-1122
Published Date: 24 February 2017
Internal mammary lymph node management – further direction
Vrana D, Gatek J
OncoTargets and Therapy 2017, 10:1111-1114
Published Date: 21 February 2017
Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non–small cell lung cancer
Sheng J, Fang W, Liu X, Xing S, Zhan J, Ma Y, Huang Y, Zhou N, Zhao H, Zhang L
OncoTargets and Therapy 2017, 10:1101-1110
Published Date: 21 February 2017
Decrease of miR-622 expression suppresses migration and invasion by targeting regulation of DYRK2 in colorectal cancer cells
Wang Y, Sun J, Wei X, Luan L, Zeng X, Wang C, Zhao W
OncoTargets and Therapy 2017, 10:1091-1100
Published Date: 22 February 2017
Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial
Guetz S, Tufman A, von Pawel J, Rittmeyer A, Borgmeier A, Ferré P, Edlich B, Huber RM
OncoTargets and Therapy 2017, 10:1081-1089
Published Date: 21 February 2017
SIX1 overexpression predicts poor prognosis and induces radioresistance through AKT signaling in esophageal squamous cell carcinoma
He Z, Li G, Tang L, Li Y
OncoTargets and Therapy 2017, 10:1071-1079
Published Date: 21 February 2017
Tbx2 confers poor prognosis in glioblastoma and promotes temozolomide resistance with change of mitochondrial dynamics
Yi F, Du J, Ni W, Liu W
OncoTargets and Therapy 2017, 10:1059-1069
Published Date: 20 February 2017
MicroRNA-320 inhibits invasion and induces apoptosis by targeting CRKL and inhibiting ERK and AKT signaling in gastric cancer cells
Zhao Y, Dong Q, Wang E
OncoTargets and Therapy 2017, 10:1049-1058
Published Date: 20 February 2017
Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma
Che K, Zhao Y, Qu X, Pang Z, Ni Y, Zhang T, Du J, Shen H
OncoTargets and Therapy 2017, 10:1039-1047
Published Date: 20 February 2017
miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1
Zheng L, Chen J, Zhou Z, He Z
OncoTargets and Therapy 2017, 10:1027-1038
Published Date: 20 February 2017
Overexpression of the long non-coding RNA, linc-UBC1, is associated with poor prognosis and facilitates cell proliferation, migration, and invasion in colorectal cancer
Gao X, Wen J, Gao P, Zhang G, Zhang G
OncoTargets and Therapy 2017, 10:1017-1026
Published Date: 22 February 2017
Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells
Mang YY, Li L, Ran JH, Zhang SN, Liu J, Li LB, Chen YM, Liu J, Gao Y, Ren G
OncoTargets and Therapy 2017, 10:1003-1016
Published Date: 20 February 2017
Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury [Corrigendum]
Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T
OncoTargets and Therapy 2017, 10:1001-1002
Published Date: 21 February 2017
Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis
Chen T, Wang H, Yang P, He ZY
OncoTargets and Therapy 2017, 10:993-1000
Published Date: 17 February 2017
Breast and cervical cancer-screening uptake among females in Ardabil, northwest Iran: a community-based study
Farzaneh E, Heydari H, Shekarchi AA, Kamran A
OncoTargets and Therapy 2017, 10:985-992
Published Date: 17 February 2017
Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis
Yi SY, Zeng LJ, Kuang Y, Cao ZJ, Zheng CJ, Zhang Y, Liao M, Yang L
OncoTargets and Therapy 2017, 10:973-984
Published Date: 17 February 2017
BRAFV600 mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study
Cohn AL, Day B, Abhyankar S, McKenna E, Riehl T, Puzanov I
OncoTargets and Therapy 2017, 10:965-971
Published Date: 17 February 2017
Axl promotes the proliferation, invasion and migration of Wilms’ tumor and can be used as a prognostic factor
Zhu S, Liu G, Fu W, Hu J, Fu K, Jia W
OncoTargets and Therapy 2017, 10:955-963
Published Date: 16 February 2017
Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis
Hao Y, Fu Q, Guo Y, Ye M, Zhao H, Wang Q, Peng X, Li Q, Wang R, Xiao W
OncoTargets and Therapy 2017, 10:945-953
Published Date: 16 February 2017
Polydatin regulates proliferation, apoptosis and autophagy in multiple myeloma cells through mTOR/p70s6k pathway
Yang B, Zhao S
OncoTargets and Therapy 2017, 10:935-944
Published Date: 16 February 2017
The superiority of 256-slice spiral computed tomography angiography for preoperative evaluation of surrounding arteries in patients with gastric cancer
Wu D, Zhao L, Liu Y, Wang J, Hu W, Feng X, Lv Z, Li Y, Yao X
OncoTargets and Therapy 2017, 10:927-933
Published Date: 16 February 2017
Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis
Lan X, Li S, Gao H, Nanding A, Quan L, Yang C, Ding S, Xue Y
OncoTargets and Therapy 2017, 10:919-926
Published Date: 16 February 2017
Association between VEGF–460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
Tan JY, Jiang L, Cheng XW, Wang CL, Chen JS, Huang XQ, Xie P, Xia DM, Wang RS, Zhang Y
OncoTargets and Therapy 2017, 10:909-918
Published Date: 15 February 2017
Carfilzomib boosted combination therapy for relapsed multiple myeloma
Steiner RE, Manasanch EE
OncoTargets and Therapy 2017, 10:895-907
Published Date: 15 February 2017
miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma
Xie F, Yuan Y, Xie L, Ran P, Xiang X, Huang Q, Qi G, Guo X, Xiao C, Zheng S
OncoTargets and Therapy 2017, 10:885-894
Published Date: 15 February 2017
Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma
Yu S, Zhou Z, Cai Q, Liang F, Han P, Chen R, Huang X
OncoTargets and Therapy 2017, 10:879-884
Published Date: 15 February 2017
The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
Liu X, Li M, Zhao F, Zhu Y, Luo Y, Kong L, Zhu H, Zhang Y, Shi F, Yu J
OncoTargets and Therapy 2017, 10:871-877
Published Date: 14 February 2017
Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis
Li Z, Yin SC, Zhang L, Liu WG, Chen B, Xing H
OncoTargets and Therapy 2017, 10:859-870
Published Date: 14 February 2017
RETRACTED ARTICLE: Correlations of microvascular blood flow of contrast-enhanced ultrasound and HGF/c-Met signaling pathway with clinicopathological features and prognosis of patients with hepatocellular carcinoma
Zhuang PH, Xu L, Gao L, Lu W, Ruan LT, Yang J
OncoTargets and Therapy 2017, 10:847-857
Published Date: 14 February 2017
Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
Zhang H, Chen F, Wang Z, Wu S
OncoTargets and Therapy 2017, 10:837-845
Published Date: 14 February 2017
The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma
Fu P, Chen F, Pan Q, Zhao X, Zhao C, Cho WC, Chen H
OncoTargets and Therapy 2017, 10:819-835
Published Date: 14 February 2017
AIM2 regulates viability and apoptosis in human colorectal cancer cells via the PI3K/Akt pathway
Chen JJ, Wang ZJ, Yu SS
OncoTargets and Therapy 2017, 10:811-817
Published Date: 13 February 2017
Effects of HGF gene polymorphisms and protein expression on transhepatic arterial chemotherapeutic embolism efficacy and prognosis in patients with primary liver cancer
Chen HY, Chen YM, Wu J, Yang FC, Lv Z, Qian YG, Zheng SS
OncoTargets and Therapy 2017, 10:803-810
Published Date: 13 February 2017
RNAi for contactin 2 inhibits proliferation of U87-glioma stem cells by downregulating AICD, EGFR, and HES1
Guo Y, Zhang PD, Zhang HT, Zhang P, Xu RX
OncoTargets and Therapy 2017, 10:791-801
Published Date: 13 February 2017
Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma
Yao X, Sun S, Zhou X, Zhang Q, Guo W, Zhang L
OncoTargets and Therapy 2017, 10:781-790
Published Date: 13 February 2017
Efficacy of eribulin in breast cancer: a short report on the emerging new data
Eslamian G, Wilson C, Young RJ
OncoTargets and Therapy 2017, 10:773-779
Published Date: 13 February 2017
Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma
Zhang W, Pang Q, Yan C, Wang Q, Yang J, Yu S, Liu X, Yuan Z, Wang P, Xiao Z
OncoTargets and Therapy 2017, 10:763-771
Published Date: 13 February 2017
MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1
Wang J, Tang W, Liao M, Liu Y, Ai X
OncoTargets and Therapy 2017, 10:753-761
Published Date: 10 February 2017
Two SNPs in the promoter region of Toll-like receptor 4 gene are not associated with smoking in Saudi Arabia
Kohailan M, Alanazi M, Rouabhia M, Al Amri A, Parine NR, Semlali A
OncoTargets and Therapy 2017, 10:745-752
Published Date: 9 February 2017
CUL4A promotes proliferation and metastasis of colorectal cancer cells by regulating H3K4 trimethylation in epithelial–mesenchymal transition
Sui X, Zhou H, Zhu L, Wang D, Fan S, Zhao W
OncoTargets and Therapy 2017, 10:735-743
Published Date: 9 February 2017
Preoperative albumin-to-globulin ratio and prognostic nutrition index predict prognosis for glioblastoma
Xu WZ, Li F, Xu ZK, Chen X, Sun B, Cao JW, Liu YG
OncoTargets and Therapy 2017, 10:725-733
Published Date: 8 February 2017
β-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma
Yang CM, Ji S, Li Y, Fu LY, Jiang T, Meng FD
OncoTargets and Therapy 2017, 10:711-724
Published Date: 20 February 2017
Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population
Zhang Z, Zhang R, Zhu J, Wang F, Yang T, Zou Y, He J, Xia H
OncoTargets and Therapy 2017, 10:703-709
Published Date: 8 February 2017
ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines
Li JP, Liu Y, Yin YH
OncoTargets and Therapy 2017, 10:691-701
Published Date: 7 February 2017
USP21 promotes cell proliferation and metastasis through suppressing EZH2 ubiquitination in bladder carcinoma
Chen Y, Zhou B, Chen D
OncoTargets and Therapy 2017, 10:681-689
Published Date: 7 February 2017
miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1
Wang JH, Wang W, Li JC, Wu LJ, Song M, Meng QG
OncoTargets and Therapy 2017, 10:667-679
Published Date: 7 February 2017
Prognostic implications of Kindlin proteins in human osteosarcoma
Ning K, Zhang H, Wang Z, Li K
OncoTargets and Therapy 2017, 10:657-665
Published Date: 7 February 2017
Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia
Huber H, Edenhofer S, Estenfelder S, Stilgenbauer S
OncoTargets and Therapy 2017, 10:645-656
Published Date: 7 February 2017
Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway
Cui Y, Li Q, Li H, Wang Y, Wang H, Chen W, Zhang S, Cao J, Liu T
OncoTargets and Therapy 2017, 10:627-643
Published Date: 3 February 2017
High expression of glucose-regulated protein 78 (GRP78) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma
Ren P, Chen C, Yue J, Zhang J, Yu Z
OncoTargets and Therapy 2017, 10:617-625
Published Date: 9 February 2017
FLT3 inhibitors: clinical potential in acute myeloid leukemia
Hospital MA, Green AS, Maciel TT, Moura IC, Leung AY, Bouscary D, Tamburini J
OncoTargets and Therapy 2017, 10:607-615
Published Date: 3 February 2017
Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
Alakel N, Middeke JM, Schetelig J, Bornhäuser M
OncoTargets and Therapy 2017, 10:597-605
Published Date: 2 February 2017
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial
Tabernero J, Kunzmann V, Scheithauer W, Reni M, Shiansong Li J, Ferrara S, Djazouli K
OncoTargets and Therapy 2017, 10:591-596
Published Date: 2 February 2017
Expression of microRNA-30c via lentivirus vector inhibits the proliferation and enhances the sensitivity of highly aggressive ccRCC Caki-1 cells to anticancer agents
Yang HL, Song EL, Shen GR, Zhu TH, Jiang TW, Shen H, Niu LP, Wang B, Lu ZY, Qian JP
OncoTargets and Therapy 2017, 10:579-590
Published Date: 2 February 2017
Exploring targeted therapy of osteosarcoma using proteomics data
Chaiyawat P, Settakorn J, Sangsin A, Teeyakasem P, Klangjorhor J, Soongkhaw A, Pruksakorn D
OncoTargets and Therapy 2017, 10:565-577
Published Date: 1 February 2017
Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung
Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, Sudo A
OncoTargets and Therapy 2017, 10:559-564
Published Date: 31 January 2017
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life
Severi S, Grassi I, Nicolini S, Sansovini M, Bongiovanni A, Paganelli G
OncoTargets and Therapy 2017, 10:551-557
Published Date: 27 January 2017
miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer
Yang F, Li Y, Xu L, Zhu Y, Gao H, Zhen L, Fang L
OncoTargets and Therapy 2017, 10:543-550
Published Date: 27 January 2017
Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer
Shao Q, Liu S, Wang W, zhang Y, Li F, Li J
OncoTargets and Therapy 2017, 10:535-541
Published Date: 31 January 2017
The clinical significance of the Ezrin gene and circulating tumor cells in osteosarcoma
Zhong GX, Feng SD, Shen RK, Wu Z, Chen F, Zhu X
OncoTargets and Therapy 2017, 10:527-533
Published Date: 8 February 2017
Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease
Váradi Z, Bánusz R, Csomor J, Kállay K, Varga E, Kertész G, Csóka M
OncoTargets and Therapy 2017, 10:521-526
Published Date: 24 January 2017
Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma
Wahid M, Jawed A, Dar SA, Mandal RK, Haque S
OncoTargets and Therapy 2017, 10:515-520
Published Date: 24 January 2017
Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma
Miguel A, Sendra L, Noé V, Ciudad CJ, Dasi F, Hervas D, Herrero MJ, Aliño SF
OncoTargets and Therapy 2017, 10:503-514
Published Date: 23 January 2017
Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis
Wang J, Yu M, Guan S, Zhang G, Wang J, Cheng Y
OncoTargets and Therapy 2017, 10:493-502
Published Date: 23 January 2017
Silence of long noncoding RNA PANDAR switches low-dose curcumin-induced senescence to apoptosis in colorectal cancer cells
Chen T, Yang P, Wang H, He ZY
OncoTargets and Therapy 2017, 10:483-491
Published Date: 21 January 2017
Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis
Shen SD, Zhong SZ, Xiao GF, Zhou HB, Huang WH
OncoTargets and Therapy 2017, 10:477-481
Published Date: 21 January 2017
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
Zulfiqar B, Mahroo A, Nasir K, Farooq RK, Jalal N, Rashid MU, Asghar K
OncoTargets and Therapy 2017, 10:463-476
Published Date: 21 January 2017
Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis
Liu W, Wang X, Sun J, Yang Y, Li W, Song J
OncoTargets and Therapy 2017, 10:453-461
Published Date: 23 January 2017
Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma
Fang S, Zhang H, Zhang Y, Xie W
OncoTargets and Therapy 2017, 10:447-452
Published Date: 18 January 2017
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel
Huang T, Yang L, Wang G, Ding G, Peng B, Wen Y, Wang Z
OncoTargets and Therapy 2017, 10:439-446
Published Date: 18 January 2017
Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2017, 10:429-437
Published Date: 18 January 2017
Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis
Liang CJ, Xu YC, Li GM, Zhao TJ, Xia F, Li GQ, Zhang D, Wu JX
OncoTargets and Therapy 2017, 10:417-428
Published Date: 18 January 2017
Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer
Zang JL, Hu Y, Xu XY, Ni J, Yan DL, Liu SW, He J, Xue J, Wu JZ, Feng JF
OncoTargets and Therapy 2017, 10:409-415
Published Date: 18 January 2017
Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature
Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC
OncoTargets and Therapy 2017, 10:397-407
Published Date: 18 January 2017
FBLN4 as candidate gene associated with long-term and short-term survival with primary glioblastoma
Li F, Li YP, Zhang K, Li Y, He P, Liu YJ, Yuan H, Lu H, Liu J, Che S, Li Z, Bie L
OncoTargets and Therapy 2017, 10:387-395
Published Date: 16 January 2017
Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study
Beisland C, Johannesen TB, Klepp O, Axcrona U, Torgersen KM, Kowalski J, Solli O, Sandin R, Oldenburg J
OncoTargets and Therapy 2017, 10:371-385
Published Date: 16 January 2017
Validation of a novel prognostic scoring system using inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma
Hirahara N, Fujii Y, Yamamoto T, Hyakudomi R, Hirayama T, Taniura T, Ishitobi K, Tajima Y
OncoTargets and Therapy 2017, 10:363-370
Published Date: 13 January 2017
Letter to the editor regarding "Prognostic role of microRNA-150 in various carcinomas: a meta-analysis"
Li M, Yang Y
OncoTargets and Therapy 2017, 10:361-362
Published Date: 13 January 2017
Advances in antiangiogenic treatment of small-cell lung cancer
Lu H, Jiang Z
OncoTargets and Therapy 2017, 10:353-359
Published Date: 12 January 2017
Chidamide in the treatment of peripheral T-cell lymphoma
Chan TS, Tse E, Kwong YL
OncoTargets and Therapy 2017, 10:347-352
Published Date: 12 January 2017
Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy
Chen J, Liu L, Xu J
OncoTargets and Therapy 2017, 10:339-345
Published Date: 11 January 2017
Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice
Yang Z, Liu J, Huang Q, Zhang Z, Zhang J, Pan Y, Yang Y, Cheng D
OncoTargets and Therapy 2017, 10:329-338
Published Date: 11 January 2017
Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis
Yin SC, Li Z, Huang JY, Miao ZF, Zhang JY, Lu CY, Xu H, Xu HM
OncoTargets and Therapy 2017, 10:319-327
Published Date: 10 January 2017
Expression of phosphatase of regenerating liver-3 is associated with prognosis of Wilms’ tumor
Sun F, Li W, Wang L, Jiao C
OncoTargets and Therapy 2017, 10:311-317
Published Date: 10 January 2017
Association of MTHFR C677T and A1298C polymorphisms with oral cancer susceptibility: evidence from a meta-analysis
Jiang S, Xu J, Zhuo Z, Hua Z
OncoTargets and Therapy 2017, 10:303-310
Published Date: 10 January 2017
Clinical outcomes of patients with metachronous second primary lung adenocarcinomas
Zhao H, Yang H, Han K, Xu J, Yao F, Zhao Y, Fan L, Gu H, Shen Z
OncoTargets and Therapy 2017, 10:295-302
Published Date: 10 January 2017
Apoptotic induction and inhibition of NF-κB signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2'-oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis: an in vitro study
Abbaspour Babaei M, Zaman Huri H, Kamalidehghan B, Yeap SK, Ahmadipour F
OncoTargets and Therapy 2017, 10:277-294
Published Date: 10 January 2017
Correlation of SASH1 expression and ultrasonographic features in breast cancer
Gong X, Wu J, Wu J, Liu J, Gu H, Shen H
OncoTargets and Therapy 2017, 10:271-276
Published Date: 10 January 2017
Strategies of temozolomide in future glioblastoma treatment
Lee CY
OncoTargets and Therapy 2017, 10:265-270
Published Date: 9 January 2017
Basal oxidative stress ratio of head and neck squamous cell carcinomas correlates with nodal metastatic spread in patients under therapy
Dequanter D, Dok R, Nuyts S
OncoTargets and Therapy 2017, 10:259-263
Published Date: 9 January 2017
RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis
Shou FY, Xu F, Li G, Zhao ZH, Mao Y, Yang FF, Wang HM, Guo HY
OncoTargets and Therapy 2017, 10:247-257
Published Date: 9 January 2017
Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection
Fan L, Yang H, Yao F, Zhao Y, Gu H, Han K, Zhao H
OncoTargets and Therapy 2017, 10:239-245
Published Date: 6 January 2017
MTHFR C677T polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls
He L, Shen Y
OncoTargets and Therapy 2017, 10:227-238
Published Date: 6 January 2017
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma
Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G
OncoTargets and Therapy 2017, 10:217-226
Published Date: 6 January 2017
Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer
Gao H, Song X, Kang T, Yan B, Feng L, Gao L, Ai L, Liu X, Yu J, Li H
OncoTargets and Therapy 2017, 10:205-216
Published Date: 5 January 2017
Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas
He T, Qiu T, Wang X, Gui H, Wang X, Hu Q, Xia H, Qi G, Wu J, Ma H
OncoTargets and Therapy 2017, 10:195-203
Published Date: 4 January 2017
The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer
Dong J, Zhang Z, Gu T, Xu SF, Dong LX, Li X, Fu BH, Fu ZZ
OncoTargets and Therapy 2017, 10:185-194
Published Date: 29 December 2016
A comparative study of target volumes based on 18F-FDG PET-CT and ten phases of 4DCT for primary thoracic squamous esophageal cancer
Guo Y, Li J, Zhang P, Zhang Y
OncoTargets and Therapy 2017, 10:177-184
Published Date: 6 January 2017
Pediatric papillary thyroid cancer: current management challenges
Verburg FA, Van Santen HM, Luster M
OncoTargets and Therapy 2017, 10:165-175
Published Date: 28 December 2016
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M
OncoTargets and Therapy 2017, 10:153-163
Published Date: 28 December 2016
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
Zhang Q, Cao J, Xue K, Liu X, Ji D, Guo Y, Hong X
OncoTargets and Therapy 2017, 10:145-151
Published Date: 22 December 2016
Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH
OncoTargets and Therapy 2017, 10:137-144
Published Date: 22 December 2016
Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker
Wu D, Cao G, Huang Z, Jin K, Hu H, Yu J, Zeng Y
OncoTargets and Therapy 2017, 10:129-135
Published Date: 23 December 2016
Comparing efficacy and survivals of initial treatments for elderly patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials
Liu X, Chen J, He YA, Meng X, Li K, He CK, Liu S
OncoTargets and Therapy 2017, 10:121-128
Published Date: 22 December 2016
High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma
Yan H, Tian R, Zhang M, Wu J, Ding M, He J
OncoTargets and Therapy 2017, 10:113-120
Published Date: 21 December 2016
nab-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors
Soliman HH
OncoTargets and Therapy 2017, 10:101-112
Published Date: 21 December 2016
Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study
Wang Y, Meng F, Liu Y, Chen X
OncoTargets and Therapy 2017, 10:95-100
Published Date: 20 December 2016
Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China
Tang H, Wu Y, Qin Y, Wang H, Wang L, Guan X, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:85-94
Published Date: 20 December 2016
RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y
OncoTargets and Therapy 2017, 10:73-83
Published Date: 5 January 2017
Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review
He W, Zou C, Tian ZK, Tan WY, Shen WX, Chen JH, Liu LP, Xu RL
OncoTargets and Therapy 2017, 10:67-72
Published Date: 20 December 2016
A novel synthetic Asiatic acid derivative induces apoptosis and inhibits proliferation and mobility of gastric cancer cells by suppressing STAT3 signaling pathway
Wang G, Jing Y, Cao LS, Gong CC, Gong ZN, Cao XR
OncoTargets and Therapy 2017, 10:55-66
Published Date: 20 December 2016
Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
Cheng Y, Xing SG, Jia WD, Huang M, Bian NN
OncoTargets and Therapy 2017, 10:47-54
Published Date: 19 December 2016
Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP
Lei R, Xue M, Zhang L, Lin ZQ
OncoTargets and Therapy 2017, 10:35-46
Published Date: 19 December 2016
Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report
Bagacean C, Tempescul A, Patiu M, Fetica B, Bumbea H, Zdrenghea M
OncoTargets and Therapy 2017, 10:31-34
Published Date: 19 December 2016
Potential role of immunotherapy in advanced non-small-cell lung cancer
de Mello RA, Veloso AF, Esrom Catarina P, Nadine S, Antoniou G
OncoTargets and Therapy 2017, 10:21-30
Published Date: 16 December 2016
J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial)
Zonca P, Maly T, Ihnat P, Peteja M, Kraft O, Kuca K
OncoTargets and Therapy 2017, 10:13-19
Published Date: 16 December 2016
Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients
Semlali A, Parine NR, Al Amri A, Azzi A, Arafah M, Kohailan M, Shaik JP, Almadi MA, Aljebreen AM, Alharbi O, Ali Azzam N, Rouabhia M, Alanazi MS
OncoTargets and Therapy 2017, 10:1-11
Published Date: 16 December 2016